{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:21:50Z","timestamp":1787955710921,"version":"build-2784847793"},"reference-count":310,"publisher":"Aging and Disease","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging and disease"],"published-print":{"date-parts":[[2025]]},"DOI":"10.14336\/ad.2024.1468","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:54:31Z","timestamp":1739289271000},"page":"0","source":"Crossref","is-referenced-by-count":4,"title":["Ovarian Aging: The Silent Catalyst of Age-Related Disorders in Female Body"],"prefix":"10.14336","author":[{"given":"Xingyu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanqu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanzhi","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiyue","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"5462","reference":[{"key":"key-10.14336\/AD.2024.1468-1","doi-asserted-by":"crossref","unstructured":"Rossiello F, Jurk D, Passos JF, d'Adda di Fagagna F (2022). Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol, 24:135-147.","DOI":"10.1038\/s41556-022-00842-x"},{"key":"key-10.14336\/AD.2024.1468-2","doi-asserted-by":"crossref","unstructured":"Dzau VJ, Inouye SK, Rowe JW, Finkelman E, Yamada T (2019). Enabling Healthful Aging for All - The National Academy of Medicine Grand Challenge in Healthy Longevity. N Engl J Med, 381:1699-1701.","DOI":"10.1056\/NEJMp1912298"},{"key":"key-10.14336\/AD.2024.1468-3","doi-asserted-by":"crossref","unstructured":"Dong L, Teh DBL, Kennedy BK, Huang Z (2023). Unraveling female reproductive senescence to enhance healthy longevity. Cell Res, 33:11-29.","DOI":"10.1038\/s41422-022-00718-7"},{"key":"key-10.14336\/AD.2024.1468-4","doi-asserted-by":"crossref","unstructured":"Davis SR, Pinkerton J, Santoro N, Simoncini T (2023). Menopause-Biology, consequences, supportive care, and therapeutic options. Cell, 186:4038-4058.","DOI":"10.1016\/j.cell.2023.08.016"},{"key":"key-10.14336\/AD.2024.1468-5","doi-asserted-by":"crossref","unstructured":"Secomandi L, Borghesan M, Velarde M, Demaria M (2022). The role of cellular senescence in female reproductive aging and the potential for senotherapeutic interventions. Hum Reprod Update, 28:172-189.","DOI":"10.1093\/humupd\/dmab038"},{"key":"key-10.14336\/AD.2024.1468-6","doi-asserted-by":"crossref","unstructured":"Marlatt KL, Pitynski-Miller DR, Gavin KM, Moreau KL, Melanson EL, Santoro N, et al. (2022). Body composition and cardiometabolic health across the menopause transition. Obesity (Silver Spring), 30:14-27.","DOI":"10.1002\/oby.23289"},{"key":"key-10.14336\/AD.2024.1468-7","doi-asserted-by":"crossref","unstructured":"Jia M, Dahlman-Wright K, Gustafsson J (2015). Estrogen receptor alpha and beta in health and disease. Best Pract Res Clin Endocrinol Metab, 29:557-568.","DOI":"10.1016\/j.beem.2015.04.008"},{"key":"key-10.14336\/AD.2024.1468-8","doi-asserted-by":"crossref","unstructured":"Rocca WA, Gazzuola Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, et al. (2018). Loss of Ovarian Hormones and Accelerated Somatic and Mental Aging. Physiology (Bethesda), 33:374-383.","DOI":"10.1152\/physiol.00024.2018"},{"key":"key-10.14336\/AD.2024.1468-9","doi-asserted-by":"crossref","unstructured":"Tsiligiannis S, Panay N, Stevenson JC (2019). Premature Ovarian Insufficiency and Long-Term Health Consequences. Curr Vasc Pharmacol, 17:604-609.","DOI":"10.2174\/1570161117666190122101611"},{"key":"key-10.14336\/AD.2024.1468-10","doi-asserted-by":"crossref","unstructured":"Greendale GA, Sternfeld B, Huang M, Han W, Karvonen-Gutierrez C, Ruppert K, et al. (2019). Changes in body composition and weight during the menopause transition. JCI Insight, 4.","DOI":"10.1172\/jci.insight.124865"},{"key":"key-10.14336\/AD.2024.1468-11","doi-asserted-by":"crossref","unstructured":"LePillouer-Prost A, Kerob D, Nielsen M, Taieb C, Maitrot Mantelet L (2020). Skin and menopause: women's point of view. J Eur Acad Dermatol Venereol, 34:e267-e269.","DOI":"10.1111\/jdv.16242"},{"key":"key-10.14336\/AD.2024.1468-12","doi-asserted-by":"crossref","unstructured":"Kattah AG, Smith CY, Gazzuola Rocca L, Grossardt BR, Garovic VD, Rocca WA (2018). CKD in Patients with Bilateral Oophorectomy. Clin J Am Soc Nephrol, 13:1649-1658.","DOI":"10.2215\/CJN.03990318"},{"key":"key-10.14336\/AD.2024.1468-13","doi-asserted-by":"crossref","unstructured":"Maldonado SS, Cedars MI, Yates KP, Wilson LA, Gill R, Terrault NA, et al. (2024). Antimullerian Hormone, a Marker of Ovarian Reserve, Is Protective Against Presence and Severity of NASH in Premenopausal Women. Clin Gastroenterol Hepatol, 22:339-346.e335.","DOI":"10.1016\/j.cgh.2023.08.020"},{"key":"key-10.14336\/AD.2024.1468-14","doi-asserted-by":"crossref","unstructured":"Goossens GH, Jocken JWE, Blaak EE (2021). Sexual dimorphism in cardiometabolic health: the role of adipose tissue, muscle and liver. Nat Rev Endocrinol, 17:47-66.","DOI":"10.1038\/s41574-020-00431-8"},{"key":"key-10.14336\/AD.2024.1468-15","doi-asserted-by":"crossref","unstructured":"Liang C, Chung HF, Dobson A, Sandin S, Weiderpass E, Mishra GD (2024). Female reproductive histories and the risk of chronic obstructive pulmonary disease. Thorax.","DOI":"10.1136\/thorax-2023-220388"},{"key":"key-10.14336\/AD.2024.1468-16","doi-asserted-by":"crossref","unstructured":"Desai S, Rajkovic A (2017). Genetics of Reproductive Aging from Gonadal Dysgenesis through Menopause. Semin Reprod Med, 35:147-159.","DOI":"10.1055\/s-0037-1599086"},{"key":"key-10.14336\/AD.2024.1468-17","doi-asserted-by":"crossref","unstructured":"Cavalcante MB, Sampaio OGM, C\u00e2mara FEA, Schneider A, de \u00c1vila BM, Prosczek J, et al. (2023). Ovarian aging in humans: potential strategies for extending reproductive lifespan. Geroscience, 45:2121-2133.","DOI":"10.1007\/s11357-023-00768-8"},{"key":"key-10.14336\/AD.2024.1468-18","doi-asserted-by":"crossref","unstructured":"Evangelinakis N, Geladari EV, Geladari CV, Kontogeorgi A, Papaioannou GK, Peppa M, et al. (2024). The influence of environmental factors on premature ovarian insufficiency and ovarian aging. Maturitas, 179:107871.","DOI":"10.1016\/j.maturitas.2023.107871"},{"key":"key-10.14336\/AD.2024.1468-19","doi-asserted-by":"crossref","unstructured":"Chandra A, Rajawat J (2021). Skeletal Aging and Osteoporosis: Mechanisms and Therapeutics. Int J Mol Sci, 22.","DOI":"10.3390\/ijms22073553"},{"key":"key-10.14336\/AD.2024.1468-20","doi-asserted-by":"crossref","unstructured":"Li L, Wang Z (2018). Ovarian Aging and Osteoporosis. Adv Exp Med Biol, 1086:199-215.","DOI":"10.1007\/978-981-13-1117-8_13"},{"key":"key-10.14336\/AD.2024.1468-21","doi-asserted-by":"crossref","unstructured":"Riggs BL, Melton LJ, 3rd (1992). The prevention and treatment of osteoporosis. N Engl J Med, 327:620-627.","DOI":"10.1056\/NEJM199208273270908"},{"key":"key-10.14336\/AD.2024.1468-22","doi-asserted-by":"crossref","unstructured":"Iqbal J, Sun L, Zaidi M (2010). Commentary-FSH and bone 2010: evolving evidence. Eur J Endocrinol, 163:173-176.","DOI":"10.1530\/EJE-10-0397"},{"key":"key-10.14336\/AD.2024.1468-23","doi-asserted-by":"crossref","unstructured":"Chen P, Li B, Ou-Yang L (2022). Role of estrogen receptors in health and disease. Front Endocrinol (Lausanne), 13:839005.","DOI":"10.3389\/fendo.2022.839005"},{"key":"key-10.14336\/AD.2024.1468-24","doi-asserted-by":"crossref","unstructured":"Melville KM, Kelly NH, Khan SA, Schimenti JC, Ross FP, Main RP, et al. (2014). Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength. J Bone Miner Res, 29:370-379.","DOI":"10.1002\/jbmr.2082"},{"key":"key-10.14336\/AD.2024.1468-25","doi-asserted-by":"crossref","unstructured":"Ernst M, Schmid C, Froesch ER (1988). Enhanced osteoblast proliferation and collagen gene expression by estradiol. Proc Natl Acad Sci U S A, 85:2307-2310.","DOI":"10.1073\/pnas.85.7.2307"},{"key":"key-10.14336\/AD.2024.1468-26","doi-asserted-by":"crossref","unstructured":"Wang LT, Chen LR, Chen KH (2023). Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview. Int J Mol Sci, 24.","DOI":"10.3390\/ijms24065814"},{"key":"key-10.14336\/AD.2024.1468-27","unstructured":"Chen KM, Ge BF, Liu XY, Ma PH, Lu MB, Bai MH, et al. (2007). Icariin inhibits the osteoclast formation induced by RANKL and macrophage-colony stimulating factor in mouse bone marrow culture. Pharmazie, 62:388-391."},{"key":"key-10.14336\/AD.2024.1468-28","doi-asserted-by":"crossref","unstructured":"Pacifici R (1996). Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis. J Bone Miner Res, 11:1043-1051.","DOI":"10.1002\/jbmr.5650110802"},{"key":"key-10.14336\/AD.2024.1468-29","doi-asserted-by":"crossref","unstructured":"Zha L, He L, Liang Y, Qin H, Yu B, Chang L, et al. (2018). TNF-\u03b1 contributes to postmenopausal osteoporosis by synergistically promoting RANKL-induced osteoclast formation. Biomed Pharmacother, 102:369-374.","DOI":"10.1016\/j.biopha.2018.03.080"},{"key":"key-10.14336\/AD.2024.1468-30","doi-asserted-by":"crossref","unstructured":"Kim JH, Jin HM, Kim K, Song I, Youn BU, Matsuo K, et al. (2009). The mechanism of osteoclast differentiation induced by IL-1. J Immunol, 183:1862-1870.","DOI":"10.4049\/jimmunol.0803007"},{"key":"key-10.14336\/AD.2024.1468-31","doi-asserted-by":"crossref","unstructured":"Pascoe D, Oursler MJ (2001). The Src signaling pathway regulates osteoclast lysosomal enzyme secretion and is rapidly modulated by estrogen. J Bone Miner Res, 16:1028-1036.","DOI":"10.1359\/jbmr.2001.16.6.1028"},{"key":"key-10.14336\/AD.2024.1468-32","doi-asserted-by":"crossref","unstructured":"Hughes DE, Dai A, Tiffee JC, Li HH, Mundy GR, Boyce BF (1996). Estrogen promotes apoptosis of murine osteoclasts mediated by TGF-beta. Nat Med, 2:1132-1136.","DOI":"10.1038\/nm1096-1132"},{"key":"key-10.14336\/AD.2024.1468-33","doi-asserted-by":"crossref","unstructured":"Naveh-Many T, Almogi G, Livni N, Silver J (1992). Estrogen receptors and biologic response in rat parathyroid tissue and C cells. J Clin Invest, 90:2434-2438.","DOI":"10.1172\/JCI116134"},{"key":"key-10.14336\/AD.2024.1468-34","doi-asserted-by":"crossref","unstructured":"Diaz de Barboza G, Guizzardi S, Tolosa de Talamoni N (2015). Molecular aspects of intestinal calcium absorption. World J Gastroenterol, 21:7142-7154.","DOI":"10.3748\/wjg.v21.i23.7142"},{"key":"key-10.14336\/AD.2024.1468-35","doi-asserted-by":"crossref","unstructured":"Guan Z, Xuanqi Z, Zhu J, Yuan W, Jia J, Zhang C, et al. (2023). Estrogen deficiency induces bone loss through the gut microbiota. Pharmacol Res, 196:106930.","DOI":"10.1016\/j.phrs.2023.106930"},{"key":"key-10.14336\/AD.2024.1468-36","doi-asserted-by":"crossref","unstructured":"Sun L, Peng Y, Sharrow AC, Iqbal J, Zhang Z, Papachristou DJ, et al. (2006). FSH directly regulates bone mass. Cell, 125:247-260.","DOI":"10.1016\/j.cell.2006.01.051"},{"key":"key-10.14336\/AD.2024.1468-37","doi-asserted-by":"crossref","unstructured":"Lobo RA, Gompel A (2022). Management of menopause: a view towards prevention. Lancet Diabetes Endocrinol, 10:457-470.","DOI":"10.1016\/S2213-8587(21)00269-2"},{"key":"key-10.14336\/AD.2024.1468-38","unstructured":"Prior JC, Seifert-Klauss VR, Giustini D, Adachi JD, Kalyan S, Goshtasebi A (2017). Estrogen-progestin therapy causes a greater increase in spinal bone mineral density than estrogen therapy - a systematic review and meta-analysis of controlled trials with direct randomization. J Musculoskelet Neuronal Interact, 17:146-154."},{"key":"key-10.14336\/AD.2024.1468-39","doi-asserted-by":"crossref","unstructured":"Samad N, Nguyen HH, Scott D, Ebeling PR, Milat F (2020). Musculoskeletal Health in Premature Ovarian Insufficiency. Part One: Muscle. Semin Reprod Med, 38:277-288.","DOI":"10.1055\/s-0040-1721797"},{"key":"key-10.14336\/AD.2024.1468-40","doi-asserted-by":"crossref","unstructured":"Lee CE, McArdle A, Griffiths RD (2007). The role of hormones, cytokines and heat shock proteins during age-related muscle loss. Clin Nutr, 26:524-534.","DOI":"10.1016\/j.clnu.2007.05.005"},{"key":"key-10.14336\/AD.2024.1468-41","doi-asserted-by":"crossref","unstructured":"Lai S, Collins BC, Colson BA, Kararigas G, Lowe DA (2016). Estradiol modulates myosin regulatory light chain phosphorylation and contractility in skeletal muscle of female mice. Am J Physiol Endocrinol Metab, 310:E724-733.","DOI":"10.1152\/ajpendo.00439.2015"},{"key":"key-10.14336\/AD.2024.1468-42","doi-asserted-by":"crossref","unstructured":"Kitajima Y, Ono Y (2016). Estrogens maintain skeletal muscle and satellite cell functions. J Endocrinol, 229:267-275.","DOI":"10.1530\/JOE-15-0476"},{"key":"key-10.14336\/AD.2024.1468-43","doi-asserted-by":"crossref","unstructured":"Samad N, Nguyen HH, Hashimura H, Pasco J, Kotowicz M, Strauss BJ, et al. (2022). Abnormal Trabecular Bone Score, Lower Bone Mineral Density and Lean Mass in Young Women With Premature Ovarian Insufficiency Are Prevented by Oestrogen Replacement. Front Endocrinol (Lausanne), 13:860853.","DOI":"10.3389\/fendo.2022.860853"},{"key":"key-10.14336\/AD.2024.1468-44","doi-asserted-by":"crossref","unstructured":"Javed AA, Mayhew AJ, Shea AK, Raina P (2019). Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis. JAMA Netw Open, 2:e1910154.","DOI":"10.1001\/jamanetworkopen.2019.10154"},{"key":"key-10.14336\/AD.2024.1468-45","doi-asserted-by":"crossref","unstructured":"Dietrich W, Haitel A, Holzer G, Huber JC, Kolbus A, Tschugguel W (2006). Estrogen receptor-beta is the predominant estrogen receptor subtype in normal human synovia. J Soc Gynecol Investig, 13:512-517.","DOI":"10.1016\/j.jsgi.2006.07.002"},{"key":"key-10.14336\/AD.2024.1468-46","doi-asserted-by":"crossref","unstructured":"Pang H, Chen S, Klyne DM, Harrich D, Ding W, Yang S, et al. (2023). Low back pain and osteoarthritis pain: a perspective of estrogen. Bone Res, 11:42.","DOI":"10.1038\/s41413-023-00280-x"},{"key":"key-10.14336\/AD.2024.1468-47","doi-asserted-by":"crossref","unstructured":"Hughbanks ML, Rodriguez-Fontan F, Kleck CJ, Burger-Van der Walt E (2021). Estrogen receptor Alpha in human knee articular cartilage of healthy and osteoarthritic females. J Orthop, 27:1-8.","DOI":"10.1016\/j.jor.2021.08.005"},{"key":"key-10.14336\/AD.2024.1468-48","unstructured":"Aquila S, De Amicis F, Santoro M, Panza S, De Rose D, Riccelli DA, et al. (2020). Conventional progesterone receptors (PR) B and PRA are expressed by human chondrocytes and can be involved in the pathogenesis of osteoarthritis. J Biol Regul Homeost Agents, 34:9-15. IORS Special Issue on Orthopedics."},{"key":"key-10.14336\/AD.2024.1468-49","doi-asserted-by":"crossref","unstructured":"Hanna FS, Wluka AE, Bell RJ, Davis SR, Cicuttini FM (2004). Osteoarthritis and the postmenopausal woman: Epidemiological, magnetic resonance imaging, and radiological findings. Semin Arthritis Rheum, 34:631-636.","DOI":"10.1016\/j.semarthrit.2004.07.007"},{"key":"key-10.14336\/AD.2024.1468-50","doi-asserted-by":"crossref","unstructured":"Robinson D, Cardozo L (2002). Overactive bladder in the female patient: the role of estrogens. Curr Urol Rep, 3:452-457.","DOI":"10.1007\/s11934-002-0096-2"},{"key":"key-10.14336\/AD.2024.1468-51","doi-asserted-by":"crossref","unstructured":"Yoshida J, Aikawa K, Yoshimura Y, Shishido K, Yanagida T, Yamaguchi O (2007). The effects of ovariectomy and estrogen replacement on acetylcholine release from nerve fibres and passive stretch-induced acetylcholine release in female rat bladder. Neurourol Urodyn, 26:1050-1055.","DOI":"10.1002\/nau.20438"},{"key":"key-10.14336\/AD.2024.1468-52","doi-asserted-by":"crossref","unstructured":"Gandhi J, Chen A, Dagur G, Suh Y, Smith N, Cali B, et al. (2016). Genitourinary syndrome of menopause: an overview of clinical manifestations, pathophysiology, etiology, evaluation, and management. Am J Obstet Gynecol, 215:704-711.","DOI":"10.1016\/j.ajog.2016.07.045"},{"key":"key-10.14336\/AD.2024.1468-53","doi-asserted-by":"crossref","unstructured":"Hong SK, Yang JH, Kim TB, Kim SW, Paick JS (2006). Effects of ovariectomy and oestrogen replacement on the function and expression of Rho-kinase in rat bladder smooth muscle. BJU Int, 98:1114-1117.","DOI":"10.1111\/j.1464-410X.2006.06486.x"},{"key":"key-10.14336\/AD.2024.1468-54","doi-asserted-by":"crossref","unstructured":"van Geelen H, Sand PK (2023). The female urethra: urethral function throughout a woman's lifetime. Int Urogynecol J, 34:1175-1186.","DOI":"10.1007\/s00192-023-05469-6"},{"key":"key-10.14336\/AD.2024.1468-55","doi-asserted-by":"crossref","unstructured":"Li L, Hong S, Li Y, Li X, Yang L, Liu J, et al. (2022). Application of estrogen for the treatment of stress urinary incontinence in mice. Arch Gynecol Obstet, 305:1115-1125.","DOI":"10.1007\/s00404-022-06435-1"},{"key":"key-10.14336\/AD.2024.1468-56","doi-asserted-by":"crossref","unstructured":"Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A (2012). Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev, 10:Cd001405.","DOI":"10.1002\/14651858.CD001405.pub3"},{"key":"key-10.14336\/AD.2024.1468-57","doi-asserted-by":"crossref","unstructured":"Moehrer B, Hextall A, Jackson S (2003). Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev:Cd001405.","DOI":"10.1002\/14651858.CD001405"},{"key":"key-10.14336\/AD.2024.1468-58","doi-asserted-by":"crossref","unstructured":"Robinson D, Toozs-Hobson P, Cardozo L (2013). The effect of hormones on the lower urinary tract. Menopause Int, 19:155-162.","DOI":"10.1177\/1754045313511398"},{"key":"key-10.14336\/AD.2024.1468-59","doi-asserted-by":"crossref","unstructured":"Hextall A, Bidmead J, Cardozo L, Hooper R (2001). The impact of the menstrual cycle on urinary symptoms and the results of urodynamic investigation. Bjog, 108:1193-1196.","DOI":"10.1111\/j.1471-0528.2003.00280.x"},{"key":"key-10.14336\/AD.2024.1468-60","doi-asserted-by":"crossref","unstructured":"Skala CE, Petry IB, Albrich S, Puhl A, Naumann G, Koelbl H (2011). The effect of genital and lower urinary tract symptoms on steroid receptor expression in women with genital prolapse. Int Urogynecol J, 22:705-712.","DOI":"10.1007\/s00192-010-1327-6"},{"key":"key-10.14336\/AD.2024.1468-61","doi-asserted-by":"crossref","unstructured":"Cardozo L, Lose G, McClish D, Versi E (2004). A systematic review of the effects of estrogens for symptoms suggestive of overactive bladder. Acta Obstet Gynecol Scand, 83:892-897.","DOI":"10.1080\/j.0001-6349.2004.00581.x"},{"key":"key-10.14336\/AD.2024.1468-62","doi-asserted-by":"crossref","unstructured":"Anglim B, Phillips C, Shynlova O, Alarab M (2022). The effect of local estrogen therapy on the urinary microbiome composition of postmenopausal women with and without recurrent urinary tract infections. Int Urogynecol J, 33:2107-2117.","DOI":"10.1007\/s00192-021-04832-9"},{"key":"key-10.14336\/AD.2024.1468-63","doi-asserted-by":"crossref","unstructured":"Sihra N, Goodman A, Zakri R, Sahai A, Malde S (2018). Nonantibiotic prevention and management of recurrent urinary tract infection. Nat Rev Urol, 15:750-776.","DOI":"10.1038\/s41585-018-0106-x"},{"key":"key-10.14336\/AD.2024.1468-64","doi-asserted-by":"crossref","unstructured":"Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE (1998). Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis, 178:446-450.","DOI":"10.1086\/515635"},{"key":"key-10.14336\/AD.2024.1468-65","doi-asserted-by":"crossref","unstructured":"Stapleton AE (2016). The Vaginal Microbiota and Urinary Tract Infection. Microbiol Spectr, 4.","DOI":"10.1128\/microbiolspec.UTI-0025-2016"},{"key":"key-10.14336\/AD.2024.1468-66","doi-asserted-by":"crossref","unstructured":"Maloney C, Oliver ML (2001). Effect of local conjugated estrogens on vaginal pH in elderly women. J Am Med Dir Assoc, 2:51-55.","DOI":"10.1016\/S1525-8610(04)70160-7"},{"key":"key-10.14336\/AD.2024.1468-67","doi-asserted-by":"crossref","unstructured":"Peters KJ (2021). What Is Genitourinary Syndrome of Menopause and Why Should We Care? Perm J, 25.","DOI":"10.7812\/TPP\/20.248"},{"key":"key-10.14336\/AD.2024.1468-68","doi-asserted-by":"crossref","unstructured":"Urbieta-Caceres VH, Syed FA, Lin J, Zhu XY, Jordan KL, Bell CC, et al. (2012). Age-dependent renal cortical microvascular loss in female mice. Am J Physiol Endocrinol Metab, 302:E979-986.","DOI":"10.1152\/ajpendo.00411.2011"},{"key":"key-10.14336\/AD.2024.1468-69","doi-asserted-by":"crossref","unstructured":"Brosnihan KB, Hodgin JB, Smithies O, Maeda N, Gallagher P (2008). Tissue-specific regulation of ACE\/ACE2 and AT1\/AT2 receptor gene expression by oestrogen in apolipoprotein E\/oestrogen receptor-alpha knock-out mice. Exp Physiol, 93:658-664.","DOI":"10.1113\/expphysiol.2007.041806"},{"key":"key-10.14336\/AD.2024.1468-70","doi-asserted-by":"crossref","unstructured":"Fung MM, Poddar S, Bettencourt R, Jassal SK, Barrett-Connor E (2011). A cross-sectional and 10-year prospective study of postmenopausal estrogen therapy and blood pressure, renal function, and albuminuria: the Rancho Bernardo Study. Menopause, 18:629-637.","DOI":"10.1097\/gme.0b013e3181fca9c4"},{"key":"key-10.14336\/AD.2024.1468-71","doi-asserted-by":"crossref","unstructured":"Gracelli JB, Souza-Menezes J, Barbosa CM, Ornellas FS, Takiya CM, Alves LM, et al. (2012). Role of estrogen and progesterone in the modulation of CNG-A1 and Na\/K+-ATPase expression in the renal cortex. Cell Physiol Biochem, 30:160-172.","DOI":"10.1159\/000339055"},{"key":"key-10.14336\/AD.2024.1468-72","doi-asserted-by":"crossref","unstructured":"Cheema MU, Irsik DL, Wang Y, Miller-Little W, Hyndman KA, Marks ES, et al. (2015). Estradiol regulates AQP2 expression in the collecting duct: a novel inhibitory role for estrogen receptor \u03b1. Am J Physiol Renal Physiol, 309:F305-317.","DOI":"10.1152\/ajprenal.00685.2014"},{"key":"key-10.14336\/AD.2024.1468-73","doi-asserted-by":"crossref","unstructured":"Chin M, Isono M, Isshiki K, Araki S, Sugimoto T, Guo B, et al. (2005). Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db\/db mice. Am J Pathol, 166:1629-1636.","DOI":"10.1016\/S0002-9440(10)62473-X"},{"key":"key-10.14336\/AD.2024.1468-74","doi-asserted-by":"crossref","unstructured":"Keck M, Romero-Aleshire MJ, Cai Q, Hoyer PB, Brooks HL (2007). Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause. Am J Physiol Renal Physiol, 293:F193-199.","DOI":"10.1152\/ajprenal.00022.2007"},{"key":"key-10.14336\/AD.2024.1468-75","doi-asserted-by":"crossref","unstructured":"Catanuto P, Doublier S, Lupia E, Fornoni A, Berho M, Karl M, et al. (2009). 17 beta-estradiol and tamoxifen upregulate estrogen receptor beta expression and control podocyte signaling pathways in a model of type 2 diabetes. Kidney Int, 75:1194-1201.","DOI":"10.1038\/ki.2009.69"},{"key":"key-10.14336\/AD.2024.1468-76","doi-asserted-by":"crossref","unstructured":"Carneiro SS, Carminati RZ, Freitas FP, Podratz PL, Balarini CM, Graceli JB, et al. (2014). Endogenous female sex hormones delay the development of renal dysfunction in apolipoprotein E-deficient mice. Lipids Health Dis, 13:176.","DOI":"10.1186\/1476-511X-13-176"},{"key":"key-10.14336\/AD.2024.1468-77","doi-asserted-by":"crossref","unstructured":"Kang DH, Yu ES, Yoon KI, Johnson R (2004). The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection. Am J Pathol, 164:679-688.","DOI":"10.1016\/S0002-9440(10)63155-0"},{"key":"key-10.14336\/AD.2024.1468-78","doi-asserted-by":"crossref","unstructured":"Wang CJ, McCauley LK (2016). Osteoporosis and Periodontitis. Curr Osteoporos Rep, 14:284-291.","DOI":"10.1007\/s11914-016-0330-3"},{"key":"key-10.14336\/AD.2024.1468-79","doi-asserted-by":"crossref","unstructured":"Chen S, Zhou D, Liu O, Chen H, Wang Y, Zhou Y (2022). Cellular Senescence and Periodontitis: Mechanisms and Therapeutics. Biology(Basel), 11.","DOI":"10.3390\/biology11101419"},{"key":"key-10.14336\/AD.2024.1468-80","doi-asserted-by":"crossref","unstructured":"Ogrodnik M, Miwa S, Tchkonia T, Tiniakos D, Wilson CL, Lahat A, et al. (2017). Cellular senescence drives age-dependent hepatic steatosis. Nat Commun, 8:15691.","DOI":"10.1038\/ncomms15691"},{"key":"key-10.14336\/AD.2024.1468-81","unstructured":"Karim MF, Al-Mahtab M, Rahman S, Debnath CR (2015). Non-alcoholic Fatty Liver Disease (NAFLD)--A Review. Mymensingh Med J, 24:873-880."},{"key":"key-10.14336\/AD.2024.1468-82","doi-asserted-by":"crossref","unstructured":"Kasarinaite A, Sinton M, Saunders PTK, Hay DC (2023). The Influence of Sex Hormones in Liver Function and Disease. Cells, 12.","DOI":"10.3390\/cells12121604"},{"key":"key-10.14336\/AD.2024.1468-83","doi-asserted-by":"crossref","unstructured":"Carulli L, Lonardo A, Lombardini S, Marchesini G, Loria P (2006). Gender, fatty liver and GGT. Hepatology, 44:278-279.","DOI":"10.1002\/hep.21218"},{"key":"key-10.14336\/AD.2024.1468-84","doi-asserted-by":"crossref","unstructured":"Lefebvre P, Staels B (2021). Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease. Nat Rev Endocrinol, 17:662-670.","DOI":"10.1038\/s41574-021-00538-6"},{"key":"key-10.14336\/AD.2024.1468-85","doi-asserted-by":"crossref","unstructured":"Erkan G, Yilmaz G, Konca Degertekin C, Akyol G, Ozenirler S (2013). Presence and extent of estrogen receptor-alpha expression in patients with simple steatosis and NASH. Pathol Res Pract, 209:429-432.","DOI":"10.1016\/j.prp.2013.04.010"},{"key":"key-10.14336\/AD.2024.1468-86","doi-asserted-by":"crossref","unstructured":"Pafili K, Paschou SA, Armeni E, Polyzos SA, Goulis DG, Lambrinoudaki I (2022). Non-alcoholic fatty liver disease through the female lifespan: the role of sex hormones. J Endocrinol Invest, 45:1609-1623.","DOI":"10.1007\/s40618-022-01766-x"},{"key":"key-10.14336\/AD.2024.1468-87","doi-asserted-by":"crossref","unstructured":"Kireev RA, Tresguerres AC, Garcia C, Borras C, Ariznavarreta C, Vara E, et al. (2010). Hormonal regulation of pro-inflammatory and lipid peroxidation processes in liver of old ovariectomized female rats. Biogerontology, 11:229-243.","DOI":"10.1007\/s10522-009-9242-2"},{"key":"key-10.14336\/AD.2024.1468-88","doi-asserted-by":"crossref","unstructured":"DeJong EN, Surette MG, Bowdish DME (2020). The Gut Microbiota and Unhealthy Aging: Disentangling Cause from Consequence. Cell Host Microbe, 28:180-189.","DOI":"10.1016\/j.chom.2020.07.013"},{"key":"key-10.14336\/AD.2024.1468-89","doi-asserted-by":"crossref","unstructured":"Cross TL, Simpson AMR, Lin CY, Hottmann NM, Bhatt AP, Pellock SJ, et al. (2024). Gut microbiome responds to alteration in female sex hormone status and exacerbates metabolic dysfunction. Gut Microbes, 16:2295429.","DOI":"10.1080\/19490976.2023.2295429"},{"key":"key-10.14336\/AD.2024.1468-90","doi-asserted-by":"crossref","unstructured":"van der Giessen J, van der Woude CJ, Peppelenbosch MP, Fuhler GM (2019). A Direct Effect of Sex Hormones on Epithelial Barrier Function in Inflammatory Bowel Disease Models. Cells, 8.","DOI":"10.3390\/cells8030261"},{"key":"key-10.14336\/AD.2024.1468-91","doi-asserted-by":"crossref","unstructured":"Yang W, Xie Y, Song B, Xia C, Tang C, Li J (2019). Effects of aging and menopause on pancreatic fat fraction in healthy women population: A strobe-compliant article. Medicine (Baltimore), 98:e14451.","DOI":"10.1097\/MD.0000000000014451"},{"key":"key-10.14336\/AD.2024.1468-92","doi-asserted-by":"crossref","unstructured":"Swynghedauw B (1999). Molecular mechanisms of myocardial remodeling. Physiol Rev, 79:215-262.","DOI":"10.1152\/physrev.1999.79.1.215"},{"key":"key-10.14336\/AD.2024.1468-93","doi-asserted-by":"crossref","unstructured":"Medzikovic L, Aryan L, Eghbali M (2019). Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis. J Mol Med (Berl), 97:1385-1398.","DOI":"10.1007\/s00109-019-01833-6"},{"key":"key-10.14336\/AD.2024.1468-94","doi-asserted-by":"crossref","unstructured":"Pedram A, Razandi M, O'Mahony F, Lubahn D, Levin ER (2010). Estrogen receptor-beta prevents cardiac fibrosis. Mol Endocrinol, 24:2152-2165.","DOI":"10.1210\/me.2010-0154"},{"key":"key-10.14336\/AD.2024.1468-95","doi-asserted-by":"crossref","unstructured":"Cheng TC, Philip JL, Tabima DM, Kumari S, Yakubov B, Frump AL, et al. (2020). Estrogen receptor-\u03b1 prevents right ventricular diastolic dysfunction and fibrosis in female rats. Am J Physiol Heart Circ Physiol, 319:H1459-h1473.","DOI":"10.1152\/ajpheart.00247.2020"},{"key":"key-10.14336\/AD.2024.1468-96","doi-asserted-by":"crossref","unstructured":"Xu Y, Arenas IA, Armstrong SJ, Davidge ST (2003). Estrogen modulation of left ventricular remodeling in the aged heart. Cardiovasc Res, 57:388-394.","DOI":"10.1016\/S0008-6363(02)00705-8"},{"key":"key-10.14336\/AD.2024.1468-97","doi-asserted-by":"crossref","unstructured":"Wang H, Sun X, Lin MS, Ferrario CM, Van Remmen H, Groban L (2018). G protein-coupled estrogen receptor (GPER) deficiency induces cardiac remodeling through oxidative stress. Transl Res, 199:39-51.","DOI":"10.1016\/j.trsl.2018.04.005"},{"key":"key-10.14336\/AD.2024.1468-98","doi-asserted-by":"crossref","unstructured":"Jovanovi\u0107 A (2006). Ageing, gender and cardiac sarcolemmal K(ATP) channels. J Pharm Pharmacol, 58:1585-1589.","DOI":"10.1211\/jpp.58.12.0004"},{"key":"key-10.14336\/AD.2024.1468-99","doi-asserted-by":"crossref","unstructured":"Xing D, Nozell S, Chen YF, Hage F, Oparil S (2009). Estrogen and mechanisms of vascular protection. Arterioscler Thromb Vasc Biol, 29:289-295.","DOI":"10.1161\/ATVBAHA.108.182279"},{"key":"key-10.14336\/AD.2024.1468-100","doi-asserted-by":"crossref","unstructured":"Wang D, Oparil S, Chen YF, McCrory MA, Skibinski GA, Feng W, et al. (2005). Estrogen treatment abrogates neointima formation in human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol, 25:2094-2099.","DOI":"10.1161\/01.ATV.0000179602.85797.3f"},{"key":"key-10.14336\/AD.2024.1468-101","doi-asserted-by":"crossref","unstructured":"Xu X, Wang B, Ren C, Hu J, Greenberg DA, Chen T, et al. (2017). Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases. Aging Dis, 8:486-505.","DOI":"10.14336\/AD.2017.0507"},{"key":"key-10.14336\/AD.2024.1468-102","doi-asserted-by":"crossref","unstructured":"Hildreth KL, Kohrt WM, Moreau KL (2014). Oxidative stress contributes to large elastic arterial stiffening across the stages of the menopausal transition. Menopause, 21:624-632.","DOI":"10.1097\/GME.0000000000000116"},{"key":"key-10.14336\/AD.2024.1468-103","doi-asserted-by":"crossref","unstructured":"de Kat AC, Verschuren WM, Eijkemans MJ, Broekmans FJ, van der Schouw YT (2017). Anti-M\u00fcllerian Hormone Trajectories Are Associated With Cardiovascular Disease in Women: Results From the Doetinchem Cohort Study. Circulation, 135:556-565.","DOI":"10.1161\/CIRCULATIONAHA.116.025968"},{"key":"key-10.14336\/AD.2024.1468-104","doi-asserted-by":"crossref","unstructured":"Sato K, Takayama KI, Inoue S (2023). Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease. Front Endocrinol (Lausanne), 14:1220150.","DOI":"10.3389\/fendo.2023.1220150"},{"key":"key-10.14336\/AD.2024.1468-105","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez C, D\u00edaz F, Alonso A (2008). Neuroprotective effects of estrogens: cross-talk between estrogen and intracellular insulin signalling. Infect Disord Drug Targets, 8:65-67.","DOI":"10.2174\/187152608784139659"},{"key":"key-10.14336\/AD.2024.1468-106","doi-asserted-by":"crossref","unstructured":"Sumien N, Cunningham JT, Davis DL, Engelland R, Fadeyibi O, Farmer GE, et al. (2021). Neurodegenerative Disease: Roles for Sex, Hormones, and Oxidative Stress. Endocrinology, 162.","DOI":"10.1210\/endocr\/bqab185"},{"key":"key-10.14336\/AD.2024.1468-107","doi-asserted-by":"crossref","unstructured":"Scheltens P, De Strooper B, Kivipelto M, Holstege H, Ch\u00e9telat G, Teunissen CE, et al. (2021). Alzheimer's disease. Lancet, 397:1577-1590.","DOI":"10.1016\/S0140-6736(20)32205-4"},{"key":"key-10.14336\/AD.2024.1468-108","doi-asserted-by":"crossref","unstructured":"Xiong J, Kang SS, Wang Z, Liu X, Kuo TC, Korkmaz F, et al. (2022). FSH blockade improves cognition in mice with Alzheimer's disease. Nature, 603:470-476.","DOI":"10.1038\/s41586-022-04463-0"},{"key":"key-10.14336\/AD.2024.1468-109","doi-asserted-by":"crossref","unstructured":"Mosconi L, Berti V, Quinn C, McHugh P, Petrongolo G, Osorio RS, et al. (2017). Perimenopause and emergence of an Alzheimer's bioenergetic phenotype in brain and periphery. PLoS One, 12:e0185926.","DOI":"10.1371\/journal.pone.0185926"},{"key":"key-10.14336\/AD.2024.1468-110","doi-asserted-by":"crossref","unstructured":"Yao J, Irwin R, Chen S, Hamilton R, Cadenas E, Brinton RD (2012). Ovarian hormone loss induces bioenergetic deficits and mitochondrial \u03b2-amyloid. Neurobiol Aging, 33:1507-1521.","DOI":"10.1016\/j.neurobiolaging.2011.03.001"},{"key":"key-10.14336\/AD.2024.1468-111","doi-asserted-by":"crossref","unstructured":"Fisher DW, Bennett DA, Dong H (2018). Sexual dimorphism in predisposition to Alzheimer's disease. Neurobiol Aging, 70:308-324.","DOI":"10.1016\/j.neurobiolaging.2018.04.004"},{"key":"key-10.14336\/AD.2024.1468-112","doi-asserted-by":"crossref","unstructured":"Villaseca P, Cisternas P, Inestrosa NC (2022). Menopause and development of Alzheimer's disease: Roles of neural glucose metabolism and Wnt signaling. Front Endocrinol (Lausanne), 13:1021796.","DOI":"10.3389\/fendo.2022.1021796"},{"key":"key-10.14336\/AD.2024.1468-113","doi-asserted-by":"crossref","unstructured":"Picazo O, Espinosa-Raya J, Briones-Aranda A, Cerb\u00f3n M (2016). Ovariectomy increases the age-induced hyperphosphorylation of Tau at hippocampal CA1. Cogn Process, 17:443-449.","DOI":"10.1007\/s10339-016-0768-3"},{"key":"key-10.14336\/AD.2024.1468-114","doi-asserted-by":"crossref","unstructured":"Kara F, Belloy ME, Voncken R, Sarwari Z, Garima Y, Anckaerts C, et al. (2021). Long-term ovarian hormone deprivation alters functional connectivity, brain neurochemical profile and white matter integrity in the Tg2576 amyloid mouse model of Alzheimer's disease. Neurobiol Aging, 102:139-150.","DOI":"10.1016\/j.neurobiolaging.2021.02.011"},{"key":"key-10.14336\/AD.2024.1468-115","doi-asserted-by":"crossref","unstructured":"Hong Y, Liu Y, Yu D, Wang M, Hou Y (2019). The neuroprotection of progesterone against A\u03b2-induced NLRP3-Caspase-1 inflammasome activation via enhancing autophagy in astrocytes. Int Immunopharmacol, 74:105669.","DOI":"10.1016\/j.intimp.2019.05.054"},{"key":"key-10.14336\/AD.2024.1468-116","doi-asserted-by":"crossref","unstructured":"Radaghdam S, Karamad V, Nourazarian A, Shademan B, Khaki-Khatibi F, Nikanfar M (2021). Molecular mechanisms of sex hormones in the development and progression of Alzheimer's disease. Neurosci Lett, 764:136221.","DOI":"10.1016\/j.neulet.2021.136221"},{"key":"key-10.14336\/AD.2024.1468-117","doi-asserted-by":"crossref","unstructured":"Nilsen J, Brinton RD (2002). Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate. Endocrinology, 143:205-212.","DOI":"10.1210\/endo.143.1.8582"},{"key":"key-10.14336\/AD.2024.1468-118","doi-asserted-by":"crossref","unstructured":"Xiong J, Kang SS, Wang M, Wang Z, Xia Y, Liao J, et al. (2023). FSH and ApoE4 contribute to Alzheimer's disease-like pathogenesis via C\/EBP\u03b2\/\u03b4-secretase in female mice. Nat Commun, 14:6577.","DOI":"10.1038\/s41467-023-42282-7"},{"key":"key-10.14336\/AD.2024.1468-119","doi-asserted-by":"crossref","unstructured":"Mey M, Bhatta S, Casadesus G (2021). Luteinizing hormone and the aging brain. Vitam Horm, 115:89-104.","DOI":"10.1016\/bs.vh.2020.12.005"},{"key":"key-10.14336\/AD.2024.1468-120","doi-asserted-by":"crossref","unstructured":"Armstrong MJ, Okun MS (2020). Diagnosis and Treatment of Parkinson Disease: A Review. Jama, 323:548-560.","DOI":"10.1001\/jama.2019.22360"},{"key":"key-10.14336\/AD.2024.1468-121","doi-asserted-by":"crossref","unstructured":"Bourque M, Dluzen DE, Di Paolo T (2009). Neuroprotective actions of sex steroids in Parkinson's disease. Front Neuroendocrinol, 30:142-157.","DOI":"10.1016\/j.yfrne.2009.04.014"},{"key":"key-10.14336\/AD.2024.1468-122","doi-asserted-by":"crossref","unstructured":"Jurado-Coronel JC, Cabezas R, \u00c1vila Rodr\u00edguez MF, Echeverria V, Garc\u00eda-Segura LM, Barreto GE (2018). Sex differences in Parkinson's disease: Features on clinical symptoms, treatment outcome, sexual hormones and genetics. Front Neuroendocrinol, 50:18-30.","DOI":"10.1016\/j.yfrne.2017.09.002"},{"key":"key-10.14336\/AD.2024.1468-123","unstructured":"Li XZ, Sui CY, Chen Q, Zhuang YS, Zhang H, Zhou XP (2016). The effects and mechanism of estrogen on rats with Parkinson's disease in different age groups. Am J Transl Res, 8:4134-4146."},{"key":"key-10.14336\/AD.2024.1468-124","doi-asserted-by":"crossref","unstructured":"Rodriguez-Perez AI, Valenzuela R, Villar-Cheda B, Guerra MJ, Lanciego JL, Labandeira-Garcia JL (2010). Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease. Exp Neurol, 224:517-526.","DOI":"10.1016\/j.expneurol.2010.05.015"},{"key":"key-10.14336\/AD.2024.1468-125","doi-asserted-by":"crossref","unstructured":"Lundin JI, Ton TG, LaCroix AZ, Longstreth WT, Franklin GM, Swanson PD, et al. (2014). Formulations of hormone therapy and risk of Parkinson's disease. Mov Disord, 29:1631-1636.","DOI":"10.1002\/mds.26037"},{"key":"key-10.14336\/AD.2024.1468-126","doi-asserted-by":"crossref","unstructured":"Fernandez HH, Lapane KL (2000). Estrogen use among nursing home residents with a diagnosis of Parkinson's disease. Mov Disord, 15:1119-1124.","DOI":"10.1002\/1531-8257(200011)15:6<1119::AID-MDS1009>3.0.CO;2-0"},{"key":"key-10.14336\/AD.2024.1468-127","doi-asserted-by":"crossref","unstructured":"Parkinson Study Group POETRY Investigators (2011). A randomized pilot trial of estrogen replacement therapy in post-menopausal women with Parkinson's disease. Parkinsonism Relat Disord, 17:757-760.","DOI":"10.1016\/j.parkreldis.2011.07.007"},{"key":"key-10.14336\/AD.2024.1468-128","doi-asserted-by":"crossref","unstructured":"Wu M, Li M, Yuan J, Liang S, Chen Z, Ye M, et al. (2020). Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis. Pharmacol Res, 155:104693.","DOI":"10.1016\/j.phrs.2020.104693"},{"key":"key-10.14336\/AD.2024.1468-129","doi-asserted-by":"crossref","unstructured":"Currie LJ, Harrison MB, Trugman JM, Bennett JP, Wooten GF (2004). Postmenopausal estrogen use affects risk for Parkinson disease. Arch Neurol, 61:886-888.","DOI":"10.1001\/archneur.61.6.886"},{"key":"key-10.14336\/AD.2024.1468-130","doi-asserted-by":"crossref","unstructured":"Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM (2007). Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci U S A, 104:6013-6018.","DOI":"10.1073\/pnas.0610394104"},{"key":"key-10.14336\/AD.2024.1468-131","doi-asserted-by":"crossref","unstructured":"Rocca WA, Grossardt BR, Shuster LT (2011). Oophorectomy, menopause, estrogen treatment, and cognitive aging: clinical evidence for a window of opportunity. Brain Res, 1379:188-198.","DOI":"10.1016\/j.brainres.2010.10.031"},{"key":"key-10.14336\/AD.2024.1468-132","doi-asserted-by":"crossref","unstructured":"Armento A, Ueffing M, Clark SJ (2021). The complement system in age-related macular degeneration. Cell Mol Life Sci, 78:4487-4505.","DOI":"10.1007\/s00018-021-03796-9"},{"key":"key-10.14336\/AD.2024.1468-133","doi-asserted-by":"crossref","unstructured":"Elliot S, Catanuto P, Fernandez P, Espinosa-Heidmann D, Karl M, Korach K, et al. (2008). Subtype specific estrogen receptor action protects against changes in MMP-2 activation in mouse retinal pigmented epithelial cells. Exp Eye Res, 86:653-660.","DOI":"10.1016\/j.exer.2008.01.010"},{"key":"key-10.14336\/AD.2024.1468-134","doi-asserted-by":"crossref","unstructured":"Kaarniranta K, Machali\u0144ska A, Ver\u00e9b Z, Salminen A, Petrovski G, Kauppinen A (2015). Estrogen signalling in the pathogenesis of age-related macular degeneration. Curr Eye Res, 40:226-233.","DOI":"10.3109\/02713683.2014.925933"},{"key":"key-10.14336\/AD.2024.1468-135","doi-asserted-by":"crossref","unstructured":"Yu X, Tang Y, Li F, Frank MB, Huang H, Dozmorov I, et al. (2005). Protection against hydrogen peroxide-induced cell death in cultured human retinal pigment epithelial cells by 17beta-estradiol: a differential gene expression profile. Mech Ageing Dev, 126:1135-1145.","DOI":"10.1016\/j.mad.2005.05.005"},{"key":"key-10.14336\/AD.2024.1468-136","doi-asserted-by":"crossref","unstructured":"Jiang R, Dong J, Joo J, Geller NL, Zheng G (2011). Simple strategies for haplotype analysis of the X chromosome with application to age-related macular degeneration. Eur J Hum Genet, 19:801-806.","DOI":"10.1038\/ejhg.2011.35"},{"key":"key-10.14336\/AD.2024.1468-137","doi-asserted-by":"crossref","unstructured":"Patnaik JL, Lynch AM, Wagner BD, Echalier EL, Kohrt WM, Mathias MT, et al. (2020). Hormone Therapy as a Protective Factor for Age-Related Macular Degeneration. Ophthalmic Epidemiol, 27:148-154.","DOI":"10.1080\/09286586.2019.1701041"},{"key":"key-10.14336\/AD.2024.1468-138","doi-asserted-by":"crossref","unstructured":"Pinaud R, Tremere LA (2012). Control of central auditory processing by a brain-generated oestrogen. Nat Rev Neurosci, 13:521-527.","DOI":"10.1038\/nrn3291"},{"key":"key-10.14336\/AD.2024.1468-139","doi-asserted-by":"crossref","unstructured":"Williamson TT, Ding B, Zhu X, Frisina RD (2019). Hormone replacement therapy attenuates hearing loss: Mechanisms involving estrogen and the IGF-1 pathway. Aging Cell, 18:e12939.","DOI":"10.1111\/acel.12939"},{"key":"key-10.14336\/AD.2024.1468-140","doi-asserted-by":"crossref","unstructured":"Feng ZY, Huang TL, Li XR, Chen L, Deng S, Xu SR, et al. (2021). 17\u03b2-Estradiol promotes angiogenesis of stria vascular in cochlea of C57BL\/6J mice. Eur J Pharmacol, 913:174642.","DOI":"10.1016\/j.ejphar.2021.174642"},{"key":"key-10.14336\/AD.2024.1468-141","doi-asserted-by":"crossref","unstructured":"Thomson RS, Auduong P, Miller AT, Gurgel RK (2017). Hearing loss as a risk factor for dementia: A systematic review. Laryngoscope Investig Otolaryngol, 2:69-79.","DOI":"10.1002\/lio2.65"},{"key":"key-10.14336\/AD.2024.1468-142","doi-asserted-by":"crossref","unstructured":"Schneider JL, Rowe JH, Garcia-de-Alba C, Kim CF, Sharpe AH, Haigis MC (2021). The aging lung: Physiology, disease, and immunity. Cell, 184:1990-2019.","DOI":"10.1016\/j.cell.2021.03.005"},{"key":"key-10.14336\/AD.2024.1468-143","doi-asserted-by":"crossref","unstructured":"Ambhore NS, Kalidhindi RSR, Sathish V (2021). Sex-Steroid Signaling in Lung Diseases and Inflammation. Adv Exp Med Biol, 1303:243-273.","DOI":"10.1007\/978-3-030-63046-1_14"},{"key":"key-10.14336\/AD.2024.1468-144","doi-asserted-by":"crossref","unstructured":"Sathish V, Martin YN, Prakash YS (2015). Sex steroid signaling: implications for lung diseases. Pharmacol Ther, 150:94-108.","DOI":"10.1016\/j.pharmthera.2015.01.007"},{"key":"key-10.14336\/AD.2024.1468-145","doi-asserted-by":"crossref","unstructured":"Herring MJ, Avdalovic MV, Lasley B, Putney LF, Hyde DM (2016). Elderly Female Rhesus Macaques Preserve Lung Alveoli With Estrogen\/Progesterone Therapy. Anat Rec (Hoboken), 299:973-978.","DOI":"10.1002\/ar.23350"},{"key":"key-10.14336\/AD.2024.1468-146","doi-asserted-by":"crossref","unstructured":"Zhang X, Bao W, Fei X, Zhang Y, Zhang G, Zhou X, et al. (2018). Progesterone attenuates airway remodeling and glucocorticoid resistance in a murine model of exposing to ozone. Mol Immunol, 96:69-77.","DOI":"10.1016\/j.molimm.2018.02.009"},{"key":"key-10.14336\/AD.2024.1468-147","doi-asserted-by":"crossref","unstructured":"Barnes PJ (2020). Oxidative stress-based therapeutics in COPD. Redox Biol, 33:101544.","DOI":"10.1016\/j.redox.2020.101544"},{"key":"key-10.14336\/AD.2024.1468-148","doi-asserted-by":"crossref","unstructured":"Xie B, Chen Q, Dai Z, Jiang C, Chen X (2024). Progesterone (P4) ameliorates cigarette smoke-induced chronic obstructive pulmonary disease (COPD). Mol Med, 30:123.","DOI":"10.1186\/s10020-024-00883-y"},{"key":"key-10.14336\/AD.2024.1468-149","doi-asserted-by":"crossref","unstructured":"Massaro D, Massaro GD (2004). Estrogen regulates pulmonary alveolar formation, loss, and regeneration in mice. Am J Physiol Lung Cell Mol Physiol, 287:L1154-1159.","DOI":"10.1152\/ajplung.00228.2004"},{"key":"key-10.14336\/AD.2024.1468-150","doi-asserted-by":"crossref","unstructured":"Real FG, Svanes C, Omenaas ER, Ant\u00f2 JM, Plana E, Jarvis D, et al. (2008). Lung function, respiratory symptoms, and the menopausal transition. J Allergy Clin Immunol, 121:72-80.e73.","DOI":"10.1016\/j.jaci.2007.08.057"},{"key":"key-10.14336\/AD.2024.1468-151","doi-asserted-by":"crossref","unstructured":"Hayatbakhsh MR, Najman JM, O'Callaghan MJ, Williams GM, Paydar A, Clavarino A (2011). Association between smoking and respiratory function before and after menopause. Lung, 189:65-71.","DOI":"10.1007\/s00408-010-9269-9"},{"key":"key-10.14336\/AD.2024.1468-152","doi-asserted-by":"crossref","unstructured":"Amaral AF, Strachan DP, G\u00f3mez Real F, Burney PG, Jarvis DL (2016). Lower lung function associates with cessation of menstruation: UK Biobank data. Eur Respir J, 48:1288-1297.","DOI":"10.1183\/13993003.00412-2016"},{"key":"key-10.14336\/AD.2024.1468-153","doi-asserted-by":"crossref","unstructured":"Triebner K, Matulonga B, Johannessen A, Suske S, Benediktsd\u00f3ttir B, Demoly P, et al. (2017). Menopause Is Associated with Accelerated Lung Function Decline. Am J Respir Crit Care Med, 195:1058-1065.","DOI":"10.1164\/rccm.201605-0968OC"},{"key":"key-10.14336\/AD.2024.1468-154","doi-asserted-by":"crossref","unstructured":"Tang R, Fraser A, Magnus MC (2019). Female reproductive history in relation to chronic obstructive pulmonary disease and lung function in UK biobank: a prospective population-based cohort study. BMJ Open, 9:e030318.","DOI":"10.1136\/bmjopen-2019-030318"},{"key":"key-10.14336\/AD.2024.1468-155","doi-asserted-by":"crossref","unstructured":"Xu X, Jones M, Mishra GD (2020). Age at natural menopause and development of chronic conditions and multimorbidity: results from an Australian prospective cohort. Hum Reprod, 35:203-211.","DOI":"10.1093\/humrep\/dez259"},{"key":"key-10.14336\/AD.2024.1468-156","doi-asserted-by":"crossref","unstructured":"Rocca WA, Gazzuola-Rocca L, Smith CY, Grossardt BR, Faubion SS, Shuster LT, et al. (2016). Accelerated Accumulation of Multimorbidity After Bilateral Oophorectomy: A Population-Based Cohort Study. Mayo Clin Proc, 91:1577-1589.","DOI":"10.1016\/j.mayocp.2016.08.002"},{"key":"key-10.14336\/AD.2024.1468-157","doi-asserted-by":"crossref","unstructured":"Nguyen TT, Smith CY, Gazzuola Rocca L, Rocca WA, Vassallo R, Dulohery Scrodin MM (2022). A population-based cohort study on the risk of obstructive lung disease after bilateral oophorectomy. NPJ Prim Care Respir Med, 32:52.","DOI":"10.1038\/s41533-022-00317-4"},{"key":"key-10.14336\/AD.2024.1468-158","doi-asserted-by":"crossref","unstructured":"Yang B, Lee DH, Han K, Choi H, Kang HK, Shin DW, et al. (2022). Female Reproductive Factors and the Risk of Bronchiectasis: A Nationwide Population-Based Longitudinal Study. Biomedicines, 10.","DOI":"10.3390\/biomedicines10020303"},{"key":"key-10.14336\/AD.2024.1468-159","doi-asserted-by":"crossref","unstructured":"Brooke-Hollidge A, Conway J, Lewis A (2021). Gender differences in non-cystic fibrosis bronchiectasis severity and bacterial load: the potential role of hormones. Ther Adv Respir Dis, 15:17534666211035311.","DOI":"10.1177\/17534666211035311"},{"key":"key-10.14336\/AD.2024.1468-160","doi-asserted-by":"crossref","unstructured":"Han MK, Murray S, Fell CD, Flaherty KR, Toews GB, Myers J, et al. (2008). Sex differences in physiological progression of idiopathic pulmonary fibrosis. Eur Respir J, 31:1183-1188.","DOI":"10.1183\/09031936.00165207"},{"key":"key-10.14336\/AD.2024.1468-161","doi-asserted-by":"crossref","unstructured":"Raghu G, Chen SY, Hou Q, Yeh WS, Collard HR (2016). Incidence and prevalence of idiopathic pulmonary fibrosis in US adults 18-64\u03b2years old. Eur Respir J, 48:179-186.","DOI":"10.1183\/13993003.01653-2015"},{"key":"key-10.14336\/AD.2024.1468-162","doi-asserted-by":"crossref","unstructured":"Smith LC, Moreno S, Robertson L, Robinson S, Gant K, Bryant AJ, et al. (2018). Transforming growth factor beta1 targets estrogen receptor signaling in bronchial epithelial cells. Respir Res, 19:160.","DOI":"10.1186\/s12931-018-0861-5"},{"key":"key-10.14336\/AD.2024.1468-163","doi-asserted-by":"crossref","unstructured":"Solopov P, Colunga Biancatelli RML, Dimitropoulou C, Catravas JD (2021). Dietary Phytoestrogens Ameliorate Hydrochloric Acid-Induced Chronic Lung Injury and Pulmonary Fibrosis in Mice. Nutrients, 13.","DOI":"10.3390\/nu13103599"},{"key":"key-10.14336\/AD.2024.1468-164","doi-asserted-by":"crossref","unstructured":"Childs BG, Durik M, Baker DJ, van Deursen JM (2015). Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med, 21:1424-1435.","DOI":"10.1038\/nm.4000"},{"key":"key-10.14336\/AD.2024.1468-165","doi-asserted-by":"crossref","unstructured":"Jeong HG, Park H (2022). Metabolic Disorders in Menopause. Metabolites, 12.","DOI":"10.3390\/metabo12100954"},{"key":"key-10.14336\/AD.2024.1468-166","doi-asserted-by":"crossref","unstructured":"Bermingham KM, Linenberg I, Hall WL, Kad\u00e9 K, Franks PW, Davies R, et al. (2022). Menopause is associated with postprandial metabolism, metabolic health and lifestyle: The ZOE PREDICT study. EBioMedicine, 85:104303.","DOI":"10.1016\/j.ebiom.2022.104303"},{"key":"key-10.14336\/AD.2024.1468-167","unstructured":"World Health Organization. 2023."},{"key":"key-10.14336\/AD.2024.1468-168","unstructured":"Hales CM CM, Fryar CD, Ogden CL.2017. Prevalence of obesity and severe obesity among adults: United States, 2017-2018 key findings data from the national health and nutrition examination survey."},{"key":"key-10.14336\/AD.2024.1468-169","doi-asserted-by":"crossref","unstructured":"Lambrinoudaki I, Brincat M, Erel CT, Gambacciani M, Moen MH, Schenck-Gustafsson K, et al. (2010). EMAS position statement: managing obese postmenopausal women. Maturitas, 66:323-326.","DOI":"10.1016\/j.maturitas.2010.03.025"},{"key":"key-10.14336\/AD.2024.1468-170","doi-asserted-by":"crossref","unstructured":"Li M, Gong W, Wang S, Li Z (2022). Trends in body mass index, overweight and obesity among adults in the USA, the NHANES from 2003 to 2018: a repeat cross-sectional survey. BMJ Open, 12:e065425.","DOI":"10.1136\/bmjopen-2022-065425"},{"key":"key-10.14336\/AD.2024.1468-171","doi-asserted-by":"crossref","unstructured":"Ko SH, Kim HS (2020). Menopause-Associated Lipid Metabolic Disorders and Foods Beneficial for Postmenopausal Women. Nutrients, 12.","DOI":"10.3390\/nu12010202"},{"key":"key-10.14336\/AD.2024.1468-172","doi-asserted-by":"crossref","unstructured":"Karvonen-Gutierrez C, Kim C (2016). Association of Mid-Life Changes in Body Size, Body Composition and Obesity Status with the Menopausal Transition. Healthcare(Basel), 4.","DOI":"10.3390\/healthcare4030042"},{"key":"key-10.14336\/AD.2024.1468-173","doi-asserted-by":"crossref","unstructured":"Farahmand M, Ramezani Tehrani F, Rahmati M, Azizi F (2021). Anthropometric Indices and Age at Natural Menopause: A 15-Year Follow-up Population-Based Study. Int J Endocrinol Metab, 19:e109285.","DOI":"10.5812\/ijem.109285"},{"key":"key-10.14336\/AD.2024.1468-174","doi-asserted-by":"crossref","unstructured":"Zhang C, Zhao M, Li Z, Song Y (2020). Follicle-Stimulating Hormone Positively Associates with Metabolic Factors in Perimenopausal Women. Int J Endocrinol, 2020:7024321.","DOI":"10.1155\/2020\/7024321"},{"key":"key-10.14336\/AD.2024.1468-175","doi-asserted-by":"crossref","unstructured":"Eckel LA (2011). The ovarian hormone estradiol plays a crucial role in the control of food intake in females. Physiol Behav, 104:517-524.","DOI":"10.1016\/j.physbeh.2011.04.014"},{"key":"key-10.14336\/AD.2024.1468-176","doi-asserted-by":"crossref","unstructured":"Guthrie JR, Dennerstein L, Dudley EC (1999). Weight gain and the menopause: a 5-year prospective study. Climacteric, 2:205-211.","DOI":"10.3109\/13697139909038063"},{"key":"key-10.14336\/AD.2024.1468-177","doi-asserted-by":"crossref","unstructured":"Pu D, Tan R, Yu Q, Wu J (2017). Metabolic syndrome in menopause and associated factors: a meta-analysis. Climacteric, 20:583-591.","DOI":"10.1080\/13697137.2017.1386649"},{"key":"key-10.14336\/AD.2024.1468-178","doi-asserted-by":"crossref","unstructured":"Montazeri SA, Ramezani Tehrani F, Bidhendi Yarandi R, Erfani H, Mansournia MA, Azizi F (2019). Effect of aging, menopause, and age at natural menopause on the trend in body mass index: a 15-year population-based cohort. Fertil Steril, 111:780-786.","DOI":"10.1016\/j.fertnstert.2018.12.017"},{"key":"key-10.14336\/AD.2024.1468-179","doi-asserted-by":"crossref","unstructured":"Vryonidou A, Paschou SA, Muscogiuri G, Orio F, Goulis DG (2015). MECHANISMS IN ENDOCRINOLOGY: Metabolic syndrome through the female life cycle. Eur J Endocrinol, 173:R153-163.","DOI":"10.1530\/EJE-15-0275"},{"key":"key-10.14336\/AD.2024.1468-180","unstructured":"World Health Organization.2021. Diabetes."},{"key":"key-10.14336\/AD.2024.1468-181","doi-asserted-by":"crossref","unstructured":"de Mutsert R, Gast K, Widya R, de Koning E, Jazet I, Lamb H, et al. (2018). Associations of Abdominal Subcutaneous and Visceral Fat with Insulin Resistance and Secretion Differ Between Men and Women: The Netherlands Epidemiology of Obesity Study. Metab Syndr Relat Disord, 16:54-63.","DOI":"10.1089\/met.2017.0128"},{"key":"key-10.14336\/AD.2024.1468-182","doi-asserted-by":"crossref","unstructured":"Cre\u0163u D, Cernea S, Onea CR, Pop RM (2020). Reproductive health in women with type 2 diabetes mellitus. Hormones (Athens), 19:291-300.","DOI":"10.1007\/s42000-020-00225-7"},{"key":"key-10.14336\/AD.2024.1468-183","doi-asserted-by":"crossref","unstructured":"Fogle RH, Stanczyk FZ, Zhang X, Paulson RJ (2007). Ovarian androgen production in postmenopausal women. J Clin Endocrinol Metab, 92:3040-3043.","DOI":"10.1210\/jc.2007-0581"},{"key":"key-10.14336\/AD.2024.1468-184","doi-asserted-by":"crossref","unstructured":"Lambrinoudaki I, Paschou SA, Armeni E, Goulis DG (2022). The interplay between diabetes mellitus and menopause: clinical implications. Nat Rev Endocrinol, 18:608-622.","DOI":"10.1038\/s41574-022-00708-0"},{"key":"key-10.14336\/AD.2024.1468-185","doi-asserted-by":"crossref","unstructured":"Shen TY, Strong C, Yu T (2020). Age at menopause and mortality in Taiwan: A cohort analysis. Maturitas, 136:42-48.","DOI":"10.1016\/j.maturitas.2020.04.008"},{"key":"key-10.14336\/AD.2024.1468-186","unstructured":"Brand JS, van der Schouw YT, Onland-Moret NC, Sharp SJ, Ong KK, Khaw KT, et al. (2013). Age at menopause, reproductive life span, and type 2 diabetes risk: results from the EPIC-InterAct study. Diabetes Care, 36:1012-1019."},{"key":"key-10.14336\/AD.2024.1468-187","doi-asserted-by":"crossref","unstructured":"Anagnostis P, Christou K, Artzouchaltzi AM, Gkekas NK, Kosmidou N, Siolos P, et al. (2019). Early menopause and premature ovarian insufficiency are associated with increased risk of type 2 diabetes: a systematic review and meta-analysis. Eur J Endocrinol, 180:41-50.","DOI":"10.1530\/EJE-18-0602"},{"key":"key-10.14336\/AD.2024.1468-188","doi-asserted-by":"crossref","unstructured":"Makrantonaki E, Vogel K, Fimmel S, Oeff M, Seltmann H, Zouboulis CC (2008). Interplay of IGF-I and 17beta-estradiol at age-specific levels in human sebocytes and fibroblasts in vitro. Exp Gerontol, 43:939-946.","DOI":"10.1016\/j.exger.2008.07.005"},{"key":"key-10.14336\/AD.2024.1468-189","doi-asserted-by":"crossref","unstructured":"Grymowicz M, Rudnicka E, Podfigurna A, Napierala P, Smolarczyk R, Smolarczyk K, et al. (2020). Hormonal Effects on Hair Follicles. Int J Mol Sci, 21.","DOI":"10.3390\/ijms21155342"},{"key":"key-10.14336\/AD.2024.1468-190","doi-asserted-by":"crossref","unstructured":"Thornton MJ, Taylor AH, Mulligan K, Al-Azzawi F, Lyon CC, O'Driscoll J, et al. (2003). Oestrogen receptor beta is the predominant oestrogen receptor in human scalp skin. Exp Dermatol, 12:181-190.","DOI":"10.1034\/j.1600-0625.2003.120209.x"},{"key":"key-10.14336\/AD.2024.1468-191","doi-asserted-by":"crossref","unstructured":"Reus TL, Brohem CA, Schuck DC, Lorencini M (2020). Revisiting the effects of menopause on the skin: Functional changes, clinical studies, in vitro models and therapeutic alternatives. Mech Ageing Dev, 185:111193.","DOI":"10.1016\/j.mad.2019.111193"},{"key":"key-10.14336\/AD.2024.1468-192","doi-asserted-by":"crossref","unstructured":"Thornton MJ (2013). Estrogens and aging skin. Dermatoendocrinol, 5:264-270.","DOI":"10.4161\/derm.23872"},{"key":"key-10.14336\/AD.2024.1468-193","unstructured":"El Mohtadi M, Whitehead K, Dempsey-Hibbert N, Belboul A, Ashworth J (2021). Estrogen deficiency - a central paradigm in age-related impaired healing? Excli j, 20:99-116."},{"key":"key-10.14336\/AD.2024.1468-194","doi-asserted-by":"crossref","unstructured":"Wilkinson HN, Hardman MJ (2021). A role for estrogen in skin ageing and dermal biomechanics. Mech Ageing Dev, 197:111513.","DOI":"10.1016\/j.mad.2021.111513"},{"key":"key-10.14336\/AD.2024.1468-195","doi-asserted-by":"crossref","unstructured":"Barakat R, Oakley O, Kim H, Jin J, Ko CJ (2016). Extra-gonadal sites of estrogen biosynthesis and function. BMB Rep, 49:488-496.","DOI":"10.5483\/BMBRep.2016.49.9.141"},{"key":"key-10.14336\/AD.2024.1468-196","doi-asserted-by":"crossref","unstructured":"Brincat MP, Baron YM, Galea R (2005). Estrogens and the skin. Climacteric, 8:110-123.","DOI":"10.1080\/13697130500118100"},{"key":"key-10.14336\/AD.2024.1468-197","doi-asserted-by":"crossref","unstructured":"Leitch C, Doherty V, Gebbie A (2011). Women's perceptions of the effects of menopause and hormone replacement therapy on skin. Menopause Int, 17:11-13.","DOI":"10.1258\/mi.2011.011002"},{"key":"key-10.14336\/AD.2024.1468-198","doi-asserted-by":"crossref","unstructured":"Blume-Peytavi U, Atkin S, Gieler U, Grimalt R (2012). Skin academy: hair, skin, hormones and menopause - current status\/knowledge on the management of hair disorders in menopausal women. Eur J Dermatol, 22:310-318.","DOI":"10.1684\/ejd.2012.1692"},{"key":"key-10.14336\/AD.2024.1468-199","doi-asserted-by":"crossref","unstructured":"Csaba G (2019). Immunity and longevity. Acta Microbiol Immunol Hung, 66:1-17.","DOI":"10.1556\/030.65.2018.029"},{"key":"key-10.14336\/AD.2024.1468-200","doi-asserted-by":"crossref","unstructured":"Gameiro CM, Rom\u00e3o F, Castelo-Branco C (2010). Menopause and aging: changes in the immune system--a review. Maturitas, 67:316-320.","DOI":"10.1016\/j.maturitas.2010.08.003"},{"key":"key-10.14336\/AD.2024.1468-201","doi-asserted-by":"crossref","unstructured":"Gameiro C, Romao F (2010). Changes in the immune system during menopause and aging. Front Biosci (Elite Ed), 2:1299-1303.","DOI":"10.2741\/e190"},{"key":"key-10.14336\/AD.2024.1468-202","doi-asserted-by":"crossref","unstructured":"Smith JS, Melendy A, Rana RK, Pimenta JM (2008). Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health, 43:S5-25, S25.e21-41.","DOI":"10.1016\/j.jadohealth.2008.07.009"},{"key":"key-10.14336\/AD.2024.1468-203","doi-asserted-by":"crossref","unstructured":"Andany N, Kennedy VL, Aden M, Loutfy M (2016). Perspectives on menopause and women with HIV. Int J Womens Health, 8:1-22.","DOI":"10.2147\/IJWH.S62615"},{"key":"key-10.14336\/AD.2024.1468-204","doi-asserted-by":"crossref","unstructured":"Desai MK, Brinton RD (2019). Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne), 10:265.","DOI":"10.3389\/fendo.2019.00265"},{"key":"key-10.14336\/AD.2024.1468-205","doi-asserted-by":"crossref","unstructured":"Calleja-Agius J, Brincat MP (2015). The urogenital system and the menopause. Climacteric, 18 Suppl 1:18-22.","DOI":"10.3109\/13697137.2015.1078206"},{"key":"key-10.14336\/AD.2024.1468-206","doi-asserted-by":"crossref","unstructured":"Angelou K, Grigoriadis T, Diakosavvas M, Zacharakis D, Athanasiou S (2020). The Genitourinary Syndrome of Menopause: An Overview of the Recent Data. Cureus, 12:e7586.","DOI":"10.7759\/cureus.7586"},{"key":"key-10.14336\/AD.2024.1468-207","doi-asserted-by":"crossref","unstructured":"Portman DJ, Gass ML (2014). Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Menopause, 21:1063-1068.","DOI":"10.1097\/GME.0000000000000329"},{"key":"key-10.14336\/AD.2024.1468-208","doi-asserted-by":"crossref","unstructured":"Mitchell CM, Waetjen LE (2018). Genitourinary Changes with Aging. Obstet Gynecol Clin North Am, 45:737-750.","DOI":"10.1016\/j.ogc.2018.07.010"},{"key":"key-10.14336\/AD.2024.1468-209","doi-asserted-by":"crossref","unstructured":"Brown HW, Hegde A, Huebner M, Neels H, Barnes HC, Marquini GV, et al. (2022). International urogynecology consultation chapter 1 committee 2: Epidemiology of pelvic organ prolapse: prevalence, incidence, natural history, and service needs. Int Urogynecol J, 33:173-187.","DOI":"10.1007\/s00192-021-05018-z"},{"key":"key-10.14336\/AD.2024.1468-210","doi-asserted-by":"crossref","unstructured":"Pang H, Zhang L, Han S, Li Z, Gong J, Liu Q, et al. (2021). A nationwide population-based survey on the prevalence and risk factors of symptomatic pelvic organ prolapse in adult women in China - a pelvic organ prolapse quantification system-based study. Bjog, 128:1313-1323.","DOI":"10.1111\/1471-0528.16675"},{"key":"key-10.14336\/AD.2024.1468-211","doi-asserted-by":"crossref","unstructured":"Jackson SR, Avery NC, Tarlton JF, Eckford SD, Abrams P, Bailey AJ (1996). Changes in metabolism of collagen in genitourinary prolapse. Lancet, 347:1658-1661.","DOI":"10.1016\/S0140-6736(96)91489-0"},{"key":"key-10.14336\/AD.2024.1468-212","doi-asserted-by":"crossref","unstructured":"Lang JH, Zhu L, Sun ZJ, Chen J (2003). Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. Int J Gynaecol Obstet, 80:35-39.","DOI":"10.1016\/S0020-7292(02)00232-1"},{"key":"key-10.14336\/AD.2024.1468-213","doi-asserted-by":"crossref","unstructured":"Clark AL, Slayden OD, Hettrich K, Brenner RM (2005). Estrogen increases collagen I and III mRNA expression in the pelvic support tissues of the rhesus macaque. Am J Obstet Gynecol, 192:1523-1529.","DOI":"10.1016\/j.ajog.2004.11.042"},{"key":"key-10.14336\/AD.2024.1468-214","doi-asserted-by":"crossref","unstructured":"Zbucka-Kretowska M, Marcus-Braun N, Eboue C, Abeguile G, Wolczynski S, Kottler ML, et al. (2011). Expression of estrogen receptors in the pelvic floor of pre- and post-menopausal women presenting pelvic organ prolapse. Folia Histochem Cytobiol, 49:521-527.","DOI":"10.5603\/FHC.2011.0073"},{"key":"key-10.14336\/AD.2024.1468-215","doi-asserted-by":"crossref","unstructured":"Hansen M, Kennedy BK (2016). Does Longer Lifespan Mean Longer Healthspan? Trends Cell Biol, 26:565-568.","DOI":"10.1016\/j.tcb.2016.05.002"},{"key":"key-10.14336\/AD.2024.1468-216","doi-asserted-by":"crossref","unstructured":"Wong RY (2018). A New Strategic Approach to Successful Aging and Healthy Aging. Geriatrics(Basel), 3.","DOI":"10.3390\/geriatrics3040086"},{"key":"key-10.14336\/AD.2024.1468-217","doi-asserted-by":"crossref","unstructured":"Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E (2019). From discoveries in ageing research to therapeutics for healthy ageing. Nature, 571:183-192.","DOI":"10.1038\/s41586-019-1365-2"},{"key":"key-10.14336\/AD.2024.1468-218","doi-asserted-by":"crossref","unstructured":"Onken B, Driscoll M (2010). Metformin induces a dietary restriction-like state and the oxidative stress response to extend C. elegans Healthspan via AMPK, LKB1, and SKN-1. PLoS One, 5:e8758.","DOI":"10.1371\/journal.pone.0008758"},{"key":"key-10.14336\/AD.2024.1468-219","doi-asserted-by":"crossref","unstructured":"Martin-Montalvo A, Mercken EM, Mitchell SJ, Palacios HH, Mote PL, Scheibye-Knudsen M, et al. (2013). Metformin improves healthspan and lifespan in mice. Nat Commun, 4:2192.","DOI":"10.1038\/ncomms3192"},{"key":"key-10.14336\/AD.2024.1468-220","doi-asserted-by":"crossref","unstructured":"Ma T, Tian X, Zhang B, Li M, Wang Y, Yang C, et al. (2022). Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature, 603:159-165.","DOI":"10.1038\/s41586-022-04431-8"},{"key":"key-10.14336\/AD.2024.1468-221","doi-asserted-by":"crossref","unstructured":"Carling D (2017). AMPK signalling in health and disease. Curr Opin Cell Biol, 45:31-37.","DOI":"10.1016\/j.ceb.2017.01.005"},{"key":"key-10.14336\/AD.2024.1468-222","doi-asserted-by":"crossref","unstructured":"Castillo-Quan JI, Blackwell TK (2016). Metformin: Restraining Nucleocytoplasmic Shuttling to Fight Cancer and Aging. Cell, 167:1670-1671.","DOI":"10.1016\/j.cell.2016.11.058"},{"key":"key-10.14336\/AD.2024.1468-223","doi-asserted-by":"crossref","unstructured":"Wu L, Zhou B, Oshiro-Rapley N, Li M, Paulo JA, Webster CM, et al. (2016). An Ancient,Unified Mechanism for Metformin Growth Inhibition in C. elegans and Cancer. Cell, 167:1705-1718.e1713.","DOI":"10.1016\/j.cell.2016.11.055"},{"key":"key-10.14336\/AD.2024.1468-224","doi-asserted-by":"crossref","unstructured":"De Haes W, Frooninckx L, Van Assche R, Smolders A, Depuydt G, Billen J, et al. (2014). Metformin promotes lifespan through mitohormesis via the peroxiredoxin PRDX-2. Proc Natl Acad Sci U S A, 111:E2501-2509.","DOI":"10.1073\/pnas.1321776111"},{"key":"key-10.14336\/AD.2024.1468-225","doi-asserted-by":"crossref","unstructured":"Noren Hooten N, Martin-Montalvo A, Dluzen DF, Zhang Y, Bernier M, Zonderman AB, et al. (2016). Metformin-mediated increase in DICER1 regulates microRNA expression and cellular senescence. Aging Cell, 15:572-581.","DOI":"10.1111\/acel.12469"},{"key":"key-10.14336\/AD.2024.1468-226","doi-asserted-by":"crossref","unstructured":"Petrocelli JJ, McKenzie AI, de Hart N, Reidy PT, Mahmassani ZS, Keeble AR, et al. (2023). Disuse-induced muscle fibrosis, cellular senescence, and senescence-associated secretory phenotype in older adults are alleviated during re-ambulation with metformin pre-treatment. Aging Cell, 22:e13936.","DOI":"10.1111\/acel.13936"},{"key":"key-10.14336\/AD.2024.1468-227","doi-asserted-by":"crossref","unstructured":"Guo JM, Zhang L, Niu XC, Shu H, Wang L, Su DF, et al. (2017). Involvement of arterial baroreflex and nicotinic acetylcholine receptor \u03b17 subunit pathway in the protection of metformin against stroke in stroke-prone spontaneously hypertensive rats. Eur J Pharmacol, 798:1-8.","DOI":"10.1016\/j.ejphar.2017.01.035"},{"key":"key-10.14336\/AD.2024.1468-228","doi-asserted-by":"crossref","unstructured":"Zheng Q, Zhao J, Yuan J, Qin Y, Zhu Z, Liu J, et al. (2024). Delaying Renal Aging: Metformin Holds Promise as a Potential Treatment. Aging Dis.","DOI":"10.14336\/AD.2024.0168"},{"key":"key-10.14336\/AD.2024.1468-229","doi-asserted-by":"crossref","unstructured":"Chaudhary S, Kulkarni A (2024). Metformin: Past, Present, and Future. Curr Diab Rep, 24:119-130.","DOI":"10.1007\/s11892-024-01539-1"},{"key":"key-10.14336\/AD.2024.1468-230","doi-asserted-by":"crossref","unstructured":"Petrie JR (2024). Metformin beyond type 2 diabetes: Emerging and potential new indications. Diabetes Obes Metab, 26 Suppl 3:31-41.","DOI":"10.1111\/dom.15756"},{"key":"key-10.14336\/AD.2024.1468-231","doi-asserted-by":"crossref","unstructured":"Guarente L, Sinclair DA, Kroemer G (2024). Human trials exploring anti-aging medicines. Cell Metab, 36:354-376.","DOI":"10.1016\/j.cmet.2023.12.007"},{"key":"key-10.14336\/AD.2024.1468-232","doi-asserted-by":"crossref","unstructured":"Kulkarni AS, Brutsaert EF, Anghel V, Zhang K, Bloomgarden N, Pollak M, et al. (2018). Metformin regulates metabolic and nonmetabolic pathways in skeletal muscle and subcutaneous adipose tissues of older adults. Aging Cell, 17.","DOI":"10.1111\/acel.12723"},{"key":"key-10.14336\/AD.2024.1468-233","doi-asserted-by":"crossref","unstructured":"de Kreutzenberg SV, Ceolotto G, Cattelan A, Pagnin E, Mazzucato M, Garagnani P, et al. (2015). Metformin improves putative longevity effectors in peripheral mononuclear cells from subjects with prediabetes. A randomized controlled trial. Nutr Metab Cardiovasc Dis, 25:686-693.","DOI":"10.1016\/j.numecd.2015.03.007"},{"key":"key-10.14336\/AD.2024.1468-234","doi-asserted-by":"crossref","unstructured":"Chen S, Gan D, Lin S, Zhong Y, Chen M, Zou X, et al. (2022). Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms. Theranostics, 12:2722-2740.","DOI":"10.7150\/thno.71360"},{"key":"key-10.14336\/AD.2024.1468-235","doi-asserted-by":"crossref","unstructured":"Qin X, Du D, Chen Q, Wu M, Wu T, Wen J, et al. (2019). Metformin prevents murine ovarian aging. Aging (Albany NY), 11:3785-3794.","DOI":"10.18632\/aging.102016"},{"key":"key-10.14336\/AD.2024.1468-236","doi-asserted-by":"crossref","unstructured":"Jinno M, Kondou K, Teruya K (2010). Low-dose metformin improves pregnancy rate in in vitro fertilization repeaters without polycystic ovary syndrome: prediction of effectiveness by multiple parameters related to insulin resistance. Hormones (Athens), 9:161-170.","DOI":"10.14310\/horm.2002.1266"},{"key":"key-10.14336\/AD.2024.1468-237","doi-asserted-by":"crossref","unstructured":"Flory J, Lipska K (2019). Metformin in 2019. Jama, 321:1926-1927.","DOI":"10.1001\/jama.2019.3805"},{"key":"key-10.14336\/AD.2024.1468-238","doi-asserted-by":"crossref","unstructured":"Grozio A, Mills KF, Yoshino J, Bruzzone S, Sociali G, Tokizane K, et al. (2019). Slc12a8 is a nicotinamide mononucleotide transporter. Nat Metab, 1:47-57.","DOI":"10.1038\/s42255-018-0009-4"},{"key":"key-10.14336\/AD.2024.1468-239","doi-asserted-by":"crossref","unstructured":"Sharma A, Chabloz S, Lapides RA, Roider E, Ewald CY (2023). Potential Synergistic Supplementation of NAD+ Promoting Compounds as a Strategy for Increasing Healthspan. Nutrients, 15.","DOI":"10.3390\/nu15020445"},{"key":"key-10.14336\/AD.2024.1468-240","doi-asserted-by":"crossref","unstructured":"Hashimoto T, Horikawa M, Nomura T, Sakamoto K (2010). Nicotinamide adenine dinucleotide extends the lifespan of Caenorhabditis elegans mediated by sir-2.1 and daf-16. Biogerontology, 11:31-43.","DOI":"10.1007\/s10522-009-9225-3"},{"key":"key-10.14336\/AD.2024.1468-241","doi-asserted-by":"crossref","unstructured":"Mouchiroud L, Houtkooper RH, Moullan N, Katsyuba E, Ryu D, Cant\u00f3 C, et al. (2013). The NAD(+)\/Sirtuin Pathway Modulates Longevity through Activation of Mitochondrial UPR and FOXO Signaling. Cell, 154:430-441.","DOI":"10.1016\/j.cell.2013.06.016"},{"key":"key-10.14336\/AD.2024.1468-242","doi-asserted-by":"crossref","unstructured":"Fang EF, Kassahun H, Croteau DL, Scheibye-Knudsen M, Marosi K, Lu H, et al. (2016). NAD(+) Replenishment Improves Lifespan and Healthspan in Ataxia Telangiectasia Models via Mitophagy and DNA Repair. Cell Metab, 24:566-581.","DOI":"10.1016\/j.cmet.2016.09.004"},{"key":"key-10.14336\/AD.2024.1468-243","doi-asserted-by":"crossref","unstructured":"Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021). NAD(+) metabolism and its roles in cellular processes during ageing. Nat Rev Mol Cell Biol, 22:119-141.","DOI":"10.1038\/s41580-020-00313-x"},{"key":"key-10.14336\/AD.2024.1468-244","doi-asserted-by":"crossref","unstructured":"Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocr J, 67:153-160.","DOI":"10.1507\/endocrj.EJ19-0313"},{"key":"key-10.14336\/AD.2024.1468-245","doi-asserted-by":"crossref","unstructured":"Fukamizu Y, Uchida Y, Shigekawa A, Sato T, Kosaka H, Sakurai T (2022). Safety evaluation of \u03b2-nicotinamide mononucleotide oral administration in healthy adult men and women. Sci Rep, 12:14442.","DOI":"10.1038\/s41598-022-18272-y"},{"key":"key-10.14336\/AD.2024.1468-246","doi-asserted-by":"crossref","unstructured":"Huang H (2022). A Multicentre, Randomised, Double Blind, Parallel Design, Placebo Controlled Study to Evaluate the Efficacy and Safety of Uthever (NMN Supplement), an Orally Administered Supplementation in Middle Aged and Older Adults. Front Aging, 3:851698.","DOI":"10.3389\/fragi.2022.851698"},{"key":"key-10.14336\/AD.2024.1468-247","doi-asserted-by":"crossref","unstructured":"Yi L, Maier AB, Tao R, Lin Z, Vaidya A, Pendse S, et al. (2023). The efficacy and safety of \u03b2-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience, 45:29-43.","DOI":"10.1007\/s11357-022-00705-1"},{"key":"key-10.14336\/AD.2024.1468-248","doi-asserted-by":"crossref","unstructured":"Katayoshi T, Uehata S, Nakashima N, Nakajo T, Kitajima N, Kageyama M, et al. (2023). Nicotinamide adenine dinucleotide metabolism and arterial stiffness after long-term nicotinamide mononucleotide supplementation: a randomized, double-blind, placebo-controlled trial. Sci Rep, 13:2786.","DOI":"10.1038\/s41598-023-29787-3"},{"key":"key-10.14336\/AD.2024.1468-249","doi-asserted-by":"crossref","unstructured":"Yoshino M, Yoshino J, Kayser BD, Patti GJ, Franczyk MP, Mills KF, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372:1224-1229.","DOI":"10.1126\/science.abe9985"},{"key":"key-10.14336\/AD.2024.1468-250","doi-asserted-by":"crossref","unstructured":"Niu KM, Bao T, Gao L, Ru M, Li Y, Jiang L, et al. (2021). The Impacts of Short-Term NMN Supplementation on Serum Metabolism, Fecal Microbiota, and Telomere Length in Pre-Aging Phase. Front Nutr, 8:756243.","DOI":"10.3389\/fnut.2021.756243"},{"key":"key-10.14336\/AD.2024.1468-251","doi-asserted-by":"crossref","unstructured":"Kim M, Seol J, Sato T, Fukamizu Y, Sakurai T, Okura T (2022). Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients, 14.","DOI":"10.3390\/nu14040755"},{"key":"key-10.14336\/AD.2024.1468-252","doi-asserted-by":"crossref","unstructured":"Yang Q, Cong L, Wang Y, Luo X, Li H, Wang H, et al. (2020). Increasing ovarian NAD(+) levels improve mitochondrial functions and reverse ovarian aging. Free Radic Biol Med, 156:1-10.","DOI":"10.1016\/j.freeradbiomed.2020.05.003"},{"key":"key-10.14336\/AD.2024.1468-253","doi-asserted-by":"crossref","unstructured":"Bertoldo MJ, Listijono DR, Ho WJ, Riepsamen AH, Goss DM, Richani D, et al. (2020). NAD(+) Repletion Rescues Female Fertility during Reproductive Aging. Cell Rep, 30:1670-1681.e1677.","DOI":"10.1016\/j.celrep.2020.01.058"},{"key":"key-10.14336\/AD.2024.1468-254","doi-asserted-by":"crossref","unstructured":"Loreto A, Antoniou C, Merlini E, Gilley J, Coleman MP (2023). NMN: The NAD precursor at the intersection between axon degeneration and anti-ageing therapies. Neurosci Res, 197:18-24.","DOI":"10.1016\/j.neures.2023.01.004"},{"key":"key-10.14336\/AD.2024.1468-255","doi-asserted-by":"crossref","unstructured":"Selvarani R, Mohammed S, Richardson A (2021). Effect of rapamycin on aging and age-related diseases-past and future. Geroscience, 43:1135-1158.","DOI":"10.1007\/s11357-020-00274-1"},{"key":"key-10.14336\/AD.2024.1468-256","doi-asserted-by":"crossref","unstructured":"Mossmann D, Park S, Hall MN (2018). mTOR signalling and cellular metabolism are mutual determinants in cancer. Nat Rev Cancer, 18:744-757.","DOI":"10.1038\/s41568-018-0074-8"},{"key":"key-10.14336\/AD.2024.1468-257","doi-asserted-by":"crossref","unstructured":"Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, et al. (2009). Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature, 460:392-395.","DOI":"10.1038\/nature08221"},{"key":"key-10.14336\/AD.2024.1468-258","doi-asserted-by":"crossref","unstructured":"Calvert S, Tacutu R, Sharifi S, Teixeira R, Ghosh P, de Magalh\u00e3es JP (2016). A network pharmacology approach reveals new candidate caloric restriction mimetics in C. elegans. Aging Cell, 15:256-266.","DOI":"10.1111\/acel.12432"},{"key":"key-10.14336\/AD.2024.1468-259","doi-asserted-by":"crossref","unstructured":"Piskovatska V, Strilbytska O, Koliada A, Vaiserman A, Lushchak O (2019). Health Benefits of Anti-aging Drugs. Subcell Biochem, 91:339-392.","DOI":"10.1007\/978-981-13-3681-2_13"},{"key":"key-10.14336\/AD.2024.1468-260","doi-asserted-by":"crossref","unstructured":"Robida-Stubbs S, Glover-Cutter K, Lamming DW, Mizunuma M, Narasimhan SD, Neumann-Haefelin E, et al. (2012). TOR signaling and rapamycin influence longevity by regulating SKN-1\/Nrf and DAF-16\/FoxO. Cell Metab, 15:713-724.","DOI":"10.1016\/j.cmet.2012.04.007"},{"key":"key-10.14336\/AD.2024.1468-261","doi-asserted-by":"crossref","unstructured":"Houtkooper RH, Mouchiroud L, Ryu D, Moullan N, Katsyuba E, Knott G, et al. (2013). Mitonuclear protein imbalance as a conserved longevity mechanism. Nature, 497:451-457.","DOI":"10.1038\/nature12188"},{"key":"key-10.14336\/AD.2024.1468-262","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhang J, Wang S (2021). The Role of Rapamycin in Healthspan Extension via the Delay of Organ Aging. Ageing Res Rev, 70:101376.","DOI":"10.1016\/j.arr.2021.101376"},{"key":"key-10.14336\/AD.2024.1468-263","doi-asserted-by":"crossref","unstructured":"Dou X, Sun Y, Li J, Zhang J, Hao D, Liu W, et al. (2017). Short-term rapamycin treatment increases ovarian lifespan in young and middle-aged female mice. Aging Cell, 16:825-836.","DOI":"10.1111\/acel.12617"},{"key":"key-10.14336\/AD.2024.1468-264","doi-asserted-by":"crossref","unstructured":"Garcia DN, Saccon TD, Pradiee J, Rinc\u00f3n JAA, Andrade KRS, Rovani MT, et al. (2019). Effect of caloric restriction and rapamycin on ovarian aging in mice. Geroscience, 41:395-408.","DOI":"10.1007\/s11357-019-00087-x"},{"key":"key-10.14336\/AD.2024.1468-265","doi-asserted-by":"crossref","unstructured":"Zhang XM, Li L, Xu JJ, Wang N, Liu WJ, Lin XH, et al. (2013). Rapamycin preserves the follicle pool reserve and prolongs the ovarian lifespan of female rats via modulating mTOR activation and sirtuin expression. Gene, 523:82-87.","DOI":"10.1016\/j.gene.2013.03.039"},{"key":"key-10.14336\/AD.2024.1468-266","doi-asserted-by":"crossref","unstructured":"Luo LL, Xu JJ, Fu YC (2013). Rapamycin prolongs female reproductive lifespan. Cell Cycle, 12:3353-3354.","DOI":"10.4161\/cc.26578"},{"key":"key-10.14336\/AD.2024.1468-267","doi-asserted-by":"crossref","unstructured":"Johnson SC, Rabinovitch PS, Kaeberlein M (2013). mTOR is a key modulator of ageing and age-related disease. Nature, 493:338-345.","DOI":"10.1038\/nature11861"},{"key":"key-10.14336\/AD.2024.1468-268","doi-asserted-by":"crossref","unstructured":"Silva AL, Fusco DR, Nga HS, Takase HM, Bravin AM, Contti MM, et al. (2018). Effect of sirolimus on carotid atherosclerosis in kidney transplant recipients: data derived from a prospective randomized controlled trial. Clin Kidney J, 11:846-852.","DOI":"10.1093\/ckj\/sfy041"},{"key":"key-10.14336\/AD.2024.1468-269","doi-asserted-by":"crossref","unstructured":"Chung CL, Lawrence I, Hoffman M, Elgindi D, Nadhan K, Potnis M, et al. (2019). Topical rapamycin reduces markers of senescence and aging in human skin: an exploratory, prospective, randomized trial. Geroscience, 41:861-869.","DOI":"10.1007\/s11357-019-00113-y"},{"key":"key-10.14336\/AD.2024.1468-270","doi-asserted-by":"crossref","unstructured":"Mannick JB, Morris M, Hockey HP, Roma G, Beibel M, Kulmatycki K, et al. (2018). TORC1 inhibition enhances immune function and reduces infections in the elderly. Sci Transl Med, 10.","DOI":"10.1126\/scitranslmed.aaq1564"},{"key":"key-10.14336\/AD.2024.1468-271","doi-asserted-by":"crossref","unstructured":"Chen X, Bahramimehr F, Shahhamzehei N, Fu H, Lin S, Wang H, et al. (2024). Anti-aging effects of medicinal plants and their rapid screening using the nematode Caenorhabditis elegans. Phytomedicine, 129:155665.","DOI":"10.1016\/j.phymed.2024.155665"},{"key":"key-10.14336\/AD.2024.1468-272","doi-asserted-by":"crossref","unstructured":"Ham HJ, Park JW, Bae YS (2019). Defect of SIRT1-FoxO3a axis is associated with the production of reactive oxygen species during protein kinase CK2 downregulation-mediated cellular senescence and nematode aging. BMB Rep, 52:265-270.","DOI":"10.5483\/BMBRep.2019.52.4.156"},{"key":"key-10.14336\/AD.2024.1468-273","doi-asserted-by":"crossref","unstructured":"McCormack S, Polyak E, Ostrovsky J, Dingley SD, Rao M, Kwon YJ, et al. (2015). Pharmacologic targeting of sirtuin and PPAR signaling improves longevity and mitochondrial physiology in respiratory chain complex I mutant Caenorhabditis elegans. Mitochondrion, 22:45-59.","DOI":"10.1016\/j.mito.2015.02.005"},{"key":"key-10.14336\/AD.2024.1468-274","doi-asserted-by":"crossref","unstructured":"Rogina B, Tissenbaum HA (2024). SIRT1, resveratrol and aging. Front Genet, 15:1393181.","DOI":"10.3389\/fgene.2024.1393181"},{"key":"key-10.14336\/AD.2024.1468-275","doi-asserted-by":"crossref","unstructured":"Anton SD, Embry C, Marsiske M, Lu X, Doss H, Leeuwenburgh C, et al. (2014). Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study. Exp Gerontol, 57:181-187.","DOI":"10.1016\/j.exger.2014.05.015"},{"key":"key-10.14336\/AD.2024.1468-276","doi-asserted-by":"crossref","unstructured":"Witte AV, Kerti L, Margulies DS, Fl\u00f6el A (2014). Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci, 34:7862-7870.","DOI":"10.1523\/JNEUROSCI.0385-14.2014"},{"key":"key-10.14336\/AD.2024.1468-277","doi-asserted-by":"crossref","unstructured":"Pollack RM, Barzilai N, Anghel V, Kulkarni AS, Golden A, O'Broin P, et al. (2017). Resveratrol Improves Vascular Function and Mitochondrial Number but Not Glucose Metabolism in Older Adults. J Gerontol A Biol Sci Med Sci, 72:1703-1709.","DOI":"10.1093\/gerona\/glx041"},{"key":"key-10.14336\/AD.2024.1468-278","doi-asserted-by":"crossref","unstructured":"Moussa C, Hebron M, Huang X, Ahn J, Rissman RA, Aisen PS, et al. (2017). Resveratrol regulates neuro-inflammation and induces adaptive immunity in Alzheimer's disease. J Neuroinflammation, 14:1.","DOI":"10.1186\/s12974-016-0779-0"},{"key":"key-10.14336\/AD.2024.1468-279","doi-asserted-by":"crossref","unstructured":"Thaung Zaw JJ, Howe PRC, Wong RHX (2020). Sustained Cerebrovascular and Cognitive Benefits of Resveratrol in Postmenopausal Women. Nutrients, 12.","DOI":"10.3390\/nu12030828"},{"key":"key-10.14336\/AD.2024.1468-280","doi-asserted-by":"crossref","unstructured":"Harper SA, Bassler JR, Peramsetty S, Yang Y, Roberts LM, Drummer D, et al. (2021). Resveratrol and exercise combined to treat functional limitations in late life: A pilot randomized controlled trial. Exp Gerontol, 143:111111.","DOI":"10.1016\/j.exger.2020.111111"},{"key":"key-10.14336\/AD.2024.1468-281","doi-asserted-by":"crossref","unstructured":"Brown K, Theofanous D, Britton RG, Aburido G, Pepper C, Sri Undru S, et al. (2024). Resveratrol for the Management of Human Health: How Far Have We Come? A Systematic Review of Resveratrol Clinical Trials to Highlight Gaps and Opportunities. Int J Mol Sci, 25.","DOI":"10.3390\/ijms25020747"},{"key":"key-10.14336\/AD.2024.1468-282","doi-asserted-by":"crossref","unstructured":"Wong RHX, Evans HM, Howe PRC (2017). Resveratrol supplementation reduces pain experience by postmenopausal women. Menopause, 24:916-922.","DOI":"10.1097\/GME.0000000000000861"},{"key":"key-10.14336\/AD.2024.1468-283","doi-asserted-by":"crossref","unstructured":"Liu M, Yin Y, Ye X, Zeng M, Zhao Q, Keefe DL, et al. (2013). Resveratrol protects against age-associated infertility in mice. Hum Reprod, 28:707-717.","DOI":"10.1093\/humrep\/des437"},{"key":"key-10.14336\/AD.2024.1468-284","doi-asserted-by":"crossref","unstructured":"Liu Y, He XQ, Huang X, Ding L, Xu L, Shen YT, et al. (2013). Resveratrol protects mouse oocytes from methylglyoxal-induced oxidative damage. PLoS One, 8:e77960.","DOI":"10.1371\/journal.pone.0077960"},{"key":"key-10.14336\/AD.2024.1468-285","doi-asserted-by":"crossref","unstructured":"Jiang Y, Zhang Z, Cha L, Li L, Zhu D, Fang Z, et al. (2019). Resveratrol Plays a Protective Role against Premature Ovarian Failure and Prompts Female Germline Stem Cell Survival. Int J Mol Sci, 20.","DOI":"10.3390\/ijms20143605"},{"key":"key-10.14336\/AD.2024.1468-286","doi-asserted-by":"crossref","unstructured":"Moskalev A, Guvatova Z, Lopes IA, Beckett CW, Kennedy BK, De Magalhaes JP, et al. (2022). Targeting aging mechanisms: pharmacological perspectives. Trends Endocrinol Metab, 33:266-280.","DOI":"10.1016\/j.tem.2022.01.007"},{"key":"key-10.14336\/AD.2024.1468-287","doi-asserted-by":"crossref","unstructured":"Sasaki H, Hamatani T, Kamijo S, Iwai M, Kobanawa M, Ogawa S, et al. (2019). Impact of Oxidative Stress on Age-Associated Decline in Oocyte Developmental Competence. Front Endocrinol (Lausanne), 10:811.","DOI":"10.3389\/fendo.2019.00811"},{"key":"key-10.14336\/AD.2024.1468-288","doi-asserted-by":"crossref","unstructured":"Sato A, Kondo Y, Ishigami A (2024). The evidence to date: implications of l-ascorbic acid in the pathophysiology of aging. J Physiol Sci, 74:29.","DOI":"10.1186\/s12576-024-00922-7"},{"key":"key-10.14336\/AD.2024.1468-289","doi-asserted-by":"crossref","unstructured":"Tar\u00edn JJ, P\u00e9rez-Albal\u00e1 S, Pertusa JF, Cano A (2002). Oral administration of pharmacological doses of vitamins C and E reduces reproductive fitness and impairs the ovarian and uterine functions of female mice. Theriogenology, 57:1539-1550.","DOI":"10.1016\/S0093-691X(02)00636-2"},{"key":"key-10.14336\/AD.2024.1468-290","doi-asserted-by":"crossref","unstructured":"Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2012). Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev, 2012:Cd007176.","DOI":"10.1002\/14651858.CD007176.pub2"},{"key":"key-10.14336\/AD.2024.1468-291","doi-asserted-by":"crossref","unstructured":"Chiang JL, Shukla P, Pagidas K, Ahmed NS, Karri S, Gunn DD, et al. (2020). Mitochondria in Ovarian Aging and Reproductive Longevity. Ageing Res Rev, 63:101168.","DOI":"10.1016\/j.arr.2020.101168"},{"key":"key-10.14336\/AD.2024.1468-292","doi-asserted-by":"crossref","unstructured":"Ayunin Q, Miatmoko A, Soeratri W, Erawati T, Susanto J, Legowo D (2022). Improving the anti-ageing activity of coenzyme Q10 through protransfersome-loaded emulgel. Sci Rep, 12:906.","DOI":"10.1038\/s41598-021-04708-4"},{"key":"key-10.14336\/AD.2024.1468-293","doi-asserted-by":"crossref","unstructured":"Mortensen SA, Rosenfeldt F, Kumar A, Dolliner P, Filipiak KJ, Pella D, et al. (2014). The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial. JACC Heart Fail, 2:641-649.","DOI":"10.1016\/j.jchf.2014.06.008"},{"key":"key-10.14336\/AD.2024.1468-294","doi-asserted-by":"crossref","unstructured":"Dai X, Lu Y, Zhang M, Miao Y, Zhou C, Cui Z, et al. (2017). Melatonin improves the fertilization ability of post-ovulatory aged mouse oocytes by stabilizing ovastacin and Juno to promote sperm binding and fusion. Hum Reprod, 32:598-606.","DOI":"10.1093\/humrep\/dew362"},{"key":"key-10.14336\/AD.2024.1468-295","doi-asserted-by":"crossref","unstructured":"Huang X, Gao S, Xia W, Hou S, Wu K (2013). Folic acid facilitates in vitro maturation of mouse and Xenopus laevis oocytes. Br J Nutr, 109:1389-1395.","DOI":"10.1017\/S0007114512003248"},{"key":"key-10.14336\/AD.2024.1468-296","doi-asserted-by":"crossref","unstructured":"Akarsu S, Gode F, Isik AZ, Dikmen ZG, Tekindal MA (2017). The association between coenzyme Q10 concentrations in follicular fluid with embryo morphokinetics and pregnancy rate in assisted reproductive techniques. J Assist Reprod Genet, 34:599-605.","DOI":"10.1007\/s10815-017-0882-x"},{"key":"key-10.14336\/AD.2024.1468-297","doi-asserted-by":"crossref","unstructured":"Giannubilo SR, Orlando P, Silvestri S, Cirilli I, Marcheggiani F, Ciavattini A, et al. (2018). CoQ10 Supplementation in Patients Undergoing IVF-ET: The Relationship with Follicular Fluid Content and Oocyte Maturity. Antioxidants(Basel), 7.","DOI":"10.3390\/antiox7100141"},{"key":"key-10.14336\/AD.2024.1468-298","doi-asserted-by":"crossref","unstructured":"Gat I, Blanco Mejia S, Balakier H, Librach CL, Claessens A, Ryan EA (2016). The use of coenzyme Q10 and DHEA during IUI and IVF cycles in patients with decreased ovarian reserve. Gynecol Endocrinol, 32:534-537.","DOI":"10.3109\/09513590.2015.1137095"},{"key":"key-10.14336\/AD.2024.1468-299","doi-asserted-by":"crossref","unstructured":"Tal R, Seifer DB (2013). Potential mechanisms for racial and ethnic differences in antim\u00fcllerian hormone and ovarian reserve. Int J Endocrinol, 2013:818912.","DOI":"10.1155\/2013\/818912"},{"key":"key-10.14336\/AD.2024.1468-300","doi-asserted-by":"crossref","unstructured":"Bleil ME, Gregorich SE, McConnell D, Rosen MP, Cedars MI (2013). Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? Menopause, 20:1139-1146.","DOI":"10.1097\/GME.0b013e31828950fa"},{"key":"key-10.14336\/AD.2024.1468-301","doi-asserted-by":"crossref","unstructured":"Freeman EW, Grisso JA, Berlin J, Sammel M, Garcia-Espana B, Hollander L (2001). Symptom reports from a cohort of African American and white women in the late reproductive years. Menopause, 8:33-42.","DOI":"10.1097\/00042192-200101000-00007"},{"key":"key-10.14336\/AD.2024.1468-302","doi-asserted-by":"crossref","unstructured":"Schmiegelow MD, Hedlin H, Mackey RH, Martin LW, Vitolins MZ, Stefanick ML, et al. (2015). Race and ethnicity, obesity, metabolic health, and risk of cardiovascular disease in postmenopausal women. J Am Heart Assoc, 4.","DOI":"10.1161\/JAHA.114.001695"},{"key":"key-10.14336\/AD.2024.1468-303","doi-asserted-by":"crossref","unstructured":"Zhang X, Wang Z, Zhang D, Ye D, Zhou Y, Qin J, et al. (2023). The prevalence and treatment rate trends of osteoporosis in postmenopausal women. PLoS One, 18:e0290289.","DOI":"10.1371\/journal.pone.0290289"},{"key":"key-10.14336\/AD.2024.1468-304","doi-asserted-by":"crossref","unstructured":"Mukwege A, Harlow SD, Hood MM, Reed BD, Dugan SA, Miller JM (2024). Race\/Ethnicity and Incidence of Pelvic Organ Prolapse in Midlife Women: The Study of Women's Health Across the Nation. J Womens Health (Larchmt), 33:1042-1051.","DOI":"10.1089\/jwh.2023.0804"},{"key":"key-10.14336\/AD.2024.1468-305","doi-asserted-by":"crossref","unstructured":"Uddenberg ER, Safwan N, Saadedine M, Hurtado MD, Faubion SS, Shufelt CL (2024). Menopause transition and cardiovascular disease risk. Maturitas, 185:107974.","DOI":"10.1016\/j.maturitas.2024.107974"},{"key":"key-10.14336\/AD.2024.1468-306","doi-asserted-by":"crossref","unstructured":"Lederman S, Ottery FD, Cano A, Santoro N, Shapiro M, Stute P, et al. (2023). Fezolinetant for treatment of moderate-to-severe vasomotor symptoms associated with menopause (SKYLIGHT 1): a phase 3 randomised controlled study. Lancet, 401:1091-1102.","DOI":"10.1016\/S0140-6736(23)00085-5"},{"key":"key-10.14336\/AD.2024.1468-307","doi-asserted-by":"crossref","unstructured":"Thomas A, Belsky DW, Gu Y (2023). Healthy Lifestyle Behaviors and Biological Aging in the U.S. National Health and Nutrition Examination Surveys 1999-2018. J Gerontol A Biol Sci Med Sci, 78:1535-1542.","DOI":"10.1093\/gerona\/glad082"},{"key":"key-10.14336\/AD.2024.1468-308","doi-asserted-by":"crossref","unstructured":"Roberts SB, Silver RE, Das SK, Fielding RA, Gilhooly CH, Jacques PF, et al. (2021). Healthy Aging-Nutrition Matters: Start Early and Screen Often. Adv Nutr, 12:1438-1448.","DOI":"10.1093\/advances\/nmab032"},{"key":"key-10.14336\/AD.2024.1468-309","doi-asserted-by":"crossref","unstructured":"Mazza E, Ferro Y, Pujia R, Mare R, Maurotti S, Montalcini T, et al. (2021). Mediterranean Diet In Healthy Aging. J Nutr Health Aging, 25:1076-1083.","DOI":"10.1007\/s12603-021-1675-6"},{"key":"key-10.14336\/AD.2024.1468-310","doi-asserted-by":"crossref","unstructured":"Rusu ME, Bigman G, Ryan AS, Popa DS (2024). Investigating the Effects and Mechanisms of Combined Vitamin D and K Supplementation in Postmenopausal Women: An Up-to-Date Comprehensive Review of Clinical Studies. Nutrients, 16.","DOI":"10.3390\/nu16142356"}],"container-title":["Aging and disease"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T15:57:59Z","timestamp":1739289479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aginganddisease.org\/EN\/10.14336\/AD.2024.1468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":310,"URL":"https:\/\/doi.org\/10.14336\/ad.2024.1468","relation":{},"ISSN":["2152-5250"],"issn-type":[{"value":"2152-5250","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}